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FGF-R fibroblast growth factor receptor   
Foxa forkhead box A, a transcription factor 
GAPDH glyseraldehyde-3-phosphate-dehydrogenase 
GBM glomerular basement membrane 
GDNF glial-cell line derived growth factor 
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IF immunofluorescence 
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MAGI-1 membrane-associated guanylate kinase with an inverted domain 
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MAGUIN membrane-associated guanylate kinase interacting protein 
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ABSTRACT 
 
The slit diaphragm is a specialised cell junction between adjacent podocytes in the kidney 
glomeruli. It is required for functional glomerular filtration. The molecular composition of the slit 
diaphragm was practically uncharacterised until 1998, when nephrin was discovered. Since then, 
several new molecules, e.g. CD2-associated protein (CD2AP), podocin, α−actinin-4, FAT, 
densin, and the NEPH family members have been proposed or shown to be implicated in the 
formation and regulation of the glomerular filtration barrier and the architecture of the glomerular 
podocyte together with the previously known podocyte molecules e.g. zonula occludens-1 (ZO-
1), synaptopodin, P-cadherin, the cadherin-associated catenin complex, and the protein 
complexes in the basal and apical membrane.  
 
The central component of the slit diaphragm, nephrin, was originally supposed to be podocyte-
specific. This thesis was aimed to study the tissue distribution of nephrin expression, to 
characterise the expression of nephrin in the pancreas, to examine whether the proteins proposed 
to form the nephrin-associated complex in the kidney are expressed in the pancreas, and whether 
their localisation in the pancreas could support their presence in the nephrin-associated protein 
complex of the pancreas. In addition, one part of this thesis was addressed to study a potential 
interaction between nephrin and CD2AP, the first proposed protein of the nephrin-associated 
assembly. Furthermore, the goal of this thesis was to characterise nephrin TRAP mouse strain 
generated by random insertional mutagenesis, an alternative to targeted mutagenesis.  
 
This thesis showed that nephrin is expressed in the insulin-producing β-cells of the pancreas. 
CD2AP, FAT, densin, synaptopodin, NEPH1, NEPH3 (filtrin), and α-actinin-4 of the molecules 
proposed to form the nephrin-associated complex in the kidney were shown to be expressed in 
the pancreas. Of these, FAT, densin, and α-actinin-4 were also found in the islet β-cells. Thus, 
these results suggest that they, together with a cadherin, may belong to the nephrin-associated 
protein complex in the islets of Langerhans.  
 
Nephrin and CD2AP were found to interact in the kidney epithelial M-1 cell line. The major 
mediator of the interaction was found to be the third Src homology 3 (SH3) domain in CD2AP. 
The observed immunoreactivity pattern of podocin in M-1 cells resembled that of nephrin, and 
thus suggested a potential for an interaction between podocin and nephrin.    
 
The renal phenotype of nephrin TRAP mice closely resembled that of patients with congenital 
nephrotic syndrome of the Finnish type (CNF). No obvious pancreatic phenotype was observed 
in the preliminary studies. 
  
In conclusion, the expression of nephrin has been characterised in two terminally differentiated 
cells: the glomerular podocytes and pancreatic β-cells. In the kidney glomerulus the nephrin-
associated protein assembly is taking shape, and within it some of the protein interactions have 
been reported, such as the interactions between nephrin and CD2AP. The nephrin-associated 
protein complex in the pancreas is not identical to that in the kidney glomerulus, but the presence 
of some members of the suggested glomerular complex in the islets β-cells suggest that these 
proteins could be shared by the pancreas and kidney. In the kidney, nephrin has been shown to be 
a critical adhesion protein for the functional filtration barrier while functions of nephrin in the 
pancreas remain to be characterised.  
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REVIEW OF THE LITERATURE 
 
 
1. The pancreas    
 
1.1. Overview of the pancreas 
 
Pancreas is an elongate organ that is composed of two distinct glandular tissue types (Figure 1) 
(Klimstra, 1997). Most of the pancreas belongs to the exocrine tissue consisting of acinar, 
centroacinar, and ductal cells. The acinar cells secrete several digestion enzymes (e.g. amylase, 
lipase, nucleases, and the proenzymes of trypsin, and chymotrypsin). The centroacinar and ductal 
cells form the ductal system that empties the digestion enzymes into the duodenum at the ampulla 
of Vater. The endocrine pancreas (~1-2 % of the total pancreas) is organised into the islets of 
Langerhans. The islet α-, β-, δ-, and pancreatic polypeptide (PP)- cells produce glucagon, insulin, 
somatostatin, and pancreatic polypeptide, respectively. The β-cells are located more centrally in 
the islets while the other endocrine cells occupy the periphery of the islets (Klimstra, 1997; Orci 
and Unger, 1975).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Human pancreas. The β-cells constitute ~70 % of the islet cells while the proportions of the  
α-, δ-, and PP-cells are ~20, 5, and 1 %, respectively (Edlund, 2002). The α- and δ-cells are located 
typically in the periphery of the islets (1) while the β-cells (2) are concentrated in the core of the islets. In 
the exocrine pancreas, the centroacinar cells (3) are surrounded by the acinar cells (4). The acinar cells 
secrete digestive enzymes into the lumen of the acinus. The centroacinar cells are the outset of the ductal 
system. The ductal cells (5) form the converging ductal system opening to the duodenum.  
 
 
The proteins involved in the formation of the islet architecture (i.e. the β-cell core surrounded by 
the non-β-cells) are not thoroughly known. Of cadherins, thus far, the presence of E-, N- and R-
cadherin has been reported in the islets (Rouiller et al., 1991; Dahl et al., 1996; Esni et al., 1999). 
Cadherins have been suggested to form the basic adhesive machinery of the islet cells (Rouiller et 
Islet of Langerhans
Acinus
1
2
3
4
5
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al., 1991; Esni et al., 1999). E- and N-cadherin are expressed by both β- and non-β-cells in the 
cell contact areas (Rouiller et al., 1991; Dahl et al., 1996; Esni et al., 1999). Only R-cadherin has 
been found differentially expressed between the islet cells: at low levels mainly in the cytoplasm 
of the β-cells where its function is unknown (Esni et al., 1999; Dahl et al., 2002). In normal islets, 
no apparent clustering of cadherins occurs, and it has been suggested that the islets express 
molecules, which reduce the clustering of cadherins (Esni et al., 1999). Neural cell adhesion 
molecule (N-CAM) that is expressed by both β- and non-β-cells appears to be such a factor. Loss 
of N-CAM results in an enhanced clustering of E- and N-cadherin, and subsequently a 
reorganisation of actin and affects cell polarisation (Esni et al., 1999). In addition, loss of the N-
CAM function affects the islet cell segregation causing an unorganised distribution of the β- and 
non-β-cells (Cirulli et al., 1994; Esni et al., 1999). 
 
 
1.2. Overview of pancreatic development 
 
In the mouse, the dorsal and ventral pancreatic buds bulge from the embryonic gut endoderm by 
E9.5 and E10.5, respectively (Figure 2) (Golosow and Grobstein, 1962; Wessels and Cohen, 
1967; Edlund, 2002). Promoted by reciprocal interactions with the condensing mesenchyme, the 
endoderm-derived epithelial cells of the buds proliferate, branch, and fuse to build a single organ, 
and differentiate into exocrine and endocrine cells (Golosow and Grobstein, 1962; Wessels and 
Cohen, 1967; Fontaine and Le Douarin, 1977). The islet, acinar, and ductal cells appear to 
differentiate from common duct-like precursor cells (Fontaine and Le Douarin, 1977; Bouwens, 
1998). The early endocrine cells are detectable around E9.5-E10 while the exocrine acini and 
ducts are distinguishable by E14.5 (Sander and German, 1997; Edlund, 1998; Kim and Hebrok, 
2001; Kim and MacDonald, 2002). The endocrine cells migrate from the epithelium to the 
mesenchyme and associate to form the islets of Langerhans by E18.5 but the formation and 
maturation of the islets continues during the murine neonatal life.  
  
The signalling between the adjacent notochord and the prepatterned gut endoderm is a 
prerequisite for the development of the dorsal pancreas (Kim et al., 1997). The expression of 
Hlxb9 and Ipf1/Pdx1 is induced in the prepatterned gut endoderm. Hb9 is needed for the 
formation of the dorsal pancreatic bud from the prepatterned permissive gut endoderm (Sander 
and German, 1997; Scharfmann, 2000; Kim and MacDonald, 2002). Ipf1/Pdx-1 and other 
transcription factors, e.g. Pbx-1 and p48, are required for the commitment of the cells in the gut 
endoderm to the pancreatic fate (Kim and MacDonald, 2002). Members of the transforming 
growth factor-β (TGF-β) superfamily, such as activin and Vg1, appear to activate the pdx1 
homologue in Xenopus (Gamer and Wright, 1995; Henry et al., 1996). Activin βB, a member of 
the TGF-β family, and fibroblast growth factor-2  (FGF-2) expressed in the notochord, have been 
suggested to prevent selectively the expression of Sonic hedgehog (Shh) and Indian hedgehog 
(Ihh) signalling molecules in the prospective dorsal pancreatic region of the gut, permitting the 
region to develop into the pancreas (Apelqvist et al., 1997; Hebrok et al., 1998; Kim et al., 1997). 
The developing ventral pancreas, however, is not associated with the notochord, and therefore the 
signals repressing Shh and Ihh are suggested to originate elsewhere than from the notochord 
(Kim et al., 1997; Edlund, 1998). The cardiogenic mesoderm and the septum transversum have 
been suggested to regulate the formation of the ventral pancreatic bud (Kim and MacDonald, 
2002). 
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Figure 2. Development of the mouse pancreas. E8.5: the endoderm is prepatterned to develop into the 
pancreas (light grey). E9.5-E10.5: the pancreatic buds bulge from the endoderm and the mesenchyme 
condensates around the buds. E9.5-E14.5: reciprocal interactions between the epithelium and 
mesenchyme promote proliferation, branching of the epithelium and differentiation of the exocrine and 
endocrine pancreas. The early endocrine cells are attached to ducts (white circles). E14.5-postnatal day 1 
(P1): the endocrine cells migrate through the basal membrane into the mesenchyme where they form the 
islets. The maturation of the islets cells to glucose sensing cells occurs during the next 3-4 weeks. 
Modified from Sander and German (1997). 
 
 
The development and differentiation of the pancreatic epithelial buds depends on the presence of 
the mesenchyme and reciprocal interactions between the mesenchyme and epithelium (Golosow 
and Grobstein, 1962; Wessels and Cohen, 1967; Ronzio and Rutter, 1973). The induced Pdx-1 
makes the epithelium competent to the signals from the mesenchyme (Ahlgren et al., 1996). The 
molecules involved in the proliferation and branching of the pancreatic epithelium are not known 
in detail but FGF and epidermal growth factor receptor (EGF-R) signalling have been proposed 
to be involved (Edlund, 1998, Edlund 2002). FGF 1, 2, 7, and 10 via fibroblast growth factor 
receptors (FGF-R), expressed in the embryonic pancreatic epithelium, have been shown to 
stimulate proliferation of the epithelium and differentiation of the exocrine cells (Le Bras et al., 
1998; Miralles et al., 1999; Bhushan et al., 2001). The perturbed EGF-receptor (EGF-R) 
signalling has been shown to impair the branching morphogenesis of the pancreatic epithelium 
(Miettinen et al., 2000). EGF has been shown act as a growth factor for undifferentiated 
pancreatic cells (Cras-Meneur et al., 2001). EGF and TGF-β1 have been shown to promote the 
ductal and endocrine development, respectively (Sanvito et al., 1994), while the mesenchyme 
seems to be especially needed for the development of the exocrine acinar cells (Gittes et al., 
1996; Miralles et al., 1999). The default fate of the embryonic pancreatic epithelium has been 
proposed to be endocrine, and the mesenchyme has been suggested to act as a repressor of the 
E8.5
E9.5-E14.5
E14.5-P1
E9.5-E10.5
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endocrine default pathway (Gittes et al., 1996; Miralles et al., 1998a; Scharfmann, 2000). 
Activins and bone morphogenic proteins (BMP) act on the embryonic epithelium and have been 
proposed to support the endocrine pathway (Scharfmann, 2000). The mesenchymal follistatin 
inhibits activin and has been suggested to favour the exocrine pathway (Miralles et al., 1998a).  
 
The Notch signalling exerts its effect on the pancreatic cell differentiation (Apelqvist et al., 1999; 
Gradwohl et al., 2000; Jensen et al., 2000a; Jensen et al., 2000b). A cell with the endocrine fate 
expresses Notch ligands, like Delta or Serrate, which then activate the Notch receptors of the 
adjacent cells resulting in release of intracellular part of the Notch receptor. It together with the 
transcription factor RBP-Jκ activates hairy/enhancer-of-the-split (Hes) genes that repress the 
expression of genes, such as neurogenin-3, directing the endocrine fate. The process is called 
lateral inhibition, and target cells of lateral inhibition adopt the secondary fate differentiating into 
exocrine cells (Edlund, 2002). The early endocrine cells located scattered in the pancreatic 
epithelium migrate into the mesenchyme and reduce lateral inhibition, preserving a resource of 
cells with a primary fate and sustaining an ability to respond to inductive signals arising later 
during pancreatic development (Edlund, 2002).  
 
After migration into the mesenchyme the endocrine cells recognise each other, attach and form 
islets with the β-cell core surrounded by the other endocrine cell types (Scharfmann, 2000). TGF-
β and signalling via EGF-R are important for the activity of matrix metalloproteinases that 
degrade extracellular matrix (ECM) and enable migration of the endocrine cells into the 
mesenchyme (Miralles et al., 1998b; Miettinen et al., 2000). Not much is known about cell-cell 
and cell-matrix interactions that guide migration and subsequent aggregation of the islets, and 
formation of the islet architecture. Integrins αvβ3  and  αvβ5, present on pancreatic ductal cells and 
undifferentiated cells emerging from the ductal epithelium appear to be involved in the adhesion 
and migration (Cirulli et al., 2000). The subsequent formation of the islets may include additional 
adhesion receptors. E-, N- and R-cadherins are expressed in the islets (Dahl et al., 1996; Esni et 
al., 1999; Rouiller et al., 1991). E-cadherin has been shown to be required for the formation of 
the islets and the localisation of N-cadherin at cell-cell contacts (Dahl et al., 1996). E-cadherin 
supported by N-cadherin appears to form the basic adhesion of the islets. E- or N-cadherin are 
not differentially expressed among the endocrine cells, are therefore probably not responsible for 
the segregation of the β- and non-β-cells (Rouiller et al., 1991; Esni et al., 1999). However, Pdx-
1+/-/Hnf1α+/-, Pdx-1+/-/Hnf3β+/- and dominant negative Hnf1α transgenic mice have an abnormal 
islet architecture and a reduced E-cadherin expression (Shih et al., 2002; Yamagata et al., 2002). 
N-CAM has a role in the cell segregation maintaining the islet cell architecture (Esni et al., 
1999). In addition, N-CAM has been found to negatively regulate the islet cell polarity by 
reducing the clustering of E- and N-cadherin. In the rat, N-CAM appears to be expressed at 
higher levels in the non-β-cells (Cirulli et al., 1994) while in the mouse, the difference in the 
expression between the β- and non-β-cells was not observed (Esni et al., 1999). Among 
cadherins, only R-cadherin seems to be differentially expressed mostly in the cytoplasm of the β-
cells (Esni et al., 1999).   
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Figure 3. Hypothetical model of differentiation of the acinar-islet precursor cells on the basis of 
selected transcription factors, EGF-R/erbB1 and erbB4 signalling. According the present hypothesis 
the cells of the committed pancreas differentiate into duct cells and acinar-islet precursor cells. The acinar-
islet precursor cells differentiate further to four endocrine cell types and exocrine acinar cells. The default 
pathway has been suggested to be the development of α-cells. The erbB signalling regulates the balance 
between the endocrine cell types. Betacellulin (BTC) and EGF appear to favour the development of β-
cells while neuregulin-4 (NRG-4) has been found to stimulate the δ-cell fate. Simultaneously, BTC, EGF, 
and NRG-4 act as repressors of the default pathway. Modified from Edlund (1998), Huotari et al. (2002), 
Kim and MacDonald (2002). 
 
 
EGF-R/erbB-1 and erbB4 signalling have been reported to influence the lineage determination of 
the endocrine cells (Huotari et al., 2002). The development of β-cells is boosted by the erbB1 
ligand, betacellulin (BTC), while the erbB4 ligand, neuregulin-4 (NRG-4) appears to favour the 
development of δ-cells. Instead, both factors and EGF appear to reduce the proportion of α-cells.  
 
The β-cell differentiation is also regulated by the interactions of laminin-1 (Jiang et al., 2001). 
Laminin-1 has been shown to promote the β-cell differentiation via its interactions with α-
dystroglycan (Jiang et al., 2001). In contrast, the interactions between laminin-1 and integrin α6  
seem to favour cell proliferation and inhibit the β-cell differentiation. 
 
Several transcription factors have been implicated in the differentiation of the pancreatic cells 
(Table 1). Pdx-1 (pancreas/duodenal homeobox 1, insulin promoter factor 1, IPF-1, somatostatin 
transactivating factor 1/islet duodenal homeobox 1) is found in the dorsal gut endoderm 
committed to pancreatic development on E8.5 (Guz et al., 1995). Pdx-1 has been suggested to 
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prime the epithelium responsive to the signals of the mesenchyme (Ahlgren et al., 1996). Pdx-1-
deficient mice develop the pancreatic buds suggesting that other factors upstream prepattern the 
region for the future pancreas. The further development of the pancreatic buds, however, is 
arrested causing agenesis of the pancreas (Ahlgren et al., 1996; Offield et al., 1996). Even a point 
mutation in the IPF-1/Pdx-1 gene has been reported to cause agenesis of the human pancreas 
stressing its importance (Stoffers et al., 1997). In the transgenic mice with a β-cell specific 
deficiency of Pdx-1, insulin expression has been found to be decreased resulting in diabetes 
(Ahlgren et al., 1998). Pancreas transcription factor (Ptf)-p48 has been proposed to have a role 
in specifying the pancreatic fate in undifferentiated gut endoderm (Kawaguchi et al., 2002). Its 
expression has been found in the precursors of the pancreatic ducts, exocrine and endocrine cells 
(Kawaguchi et al., 2002). The transcription factor p48 is needed for the development of the 
exocrine pancreas and the proper spatial assembly of the endocrine pancreas, and its loss results 
in proliferation and development of pancreatic precursor cells into duodenal epithelium (Krapp et 
al., 1998). Neurogenin-3 is expressed in scattered cells in the pancreatic epithelium and is 
required for the specification of common endocrine precursors. Loss of neurogenin-3 causes lack 
of endocrine cells and diabetes (Gradwohl et al., 2000). The pancreatic bud, mesenchyme, and 
islet cells express Islet-1 (Isl-1) crucial for the development of the dorsal mesenchyme, endocrine 
and exocrine cells (Ahlgren et al., 1997). The exocrine pancreas, however, develops despite loss 
of Isl-1 in the presence of mesenchyme. Beta-2 (neurogenic differentiation, NeuroD) is 
expressed in the endocrine cells in the pancreas (Naya et al., 1997). Beta-2 appears to play a role 
in the islet morphogenesis and also influence on the secretion of the acinar cells (Naya et al., 
1997). In the pancreas, Paired box 6 (Pax-6) is restricted to the pancreatic bud and islet cells. It 
is required for the transcription of the pancreatic hormone genes and development of the islets 
(Turque et al., 1994; Sander et al., 1997). Pax-6 appears especially important for the 
differentiation of the α-cells (St-Onge et al., 1997). Loss of Pax-6 has been shown to reduce the 
numbers of all pancreatic endocrine cells, their hormone production, and to result in disorganised 
islets. The expression of Pax-6 is shown to depend on the expression of Isl-1 (Edlund, 1998). 
Pax-4 has been suggested to specify the β-, δ- or α-cell fates. The presence of Pax-4 is needed 
for the development of the β- and δ-cells while it is absent in the α-cells (Sosa-Pineda et al., 
1997). NK-related homeobox 2.2 (Nkx2.2) is required for the terminal differentiation of the β-
cells but is also expressed in the α- and PP-cells (Sussel et al., 1998). Nkx2.2-deficient mice lack 
insulin production, glucose transporter 2, and Nkx6.1. Nkx6.1 is expressed in the cells of the 
early pancreatic bud (Sander and German, 1997). Later, the expression is restricted to the β-cells, 
and Nkx6.1-deficient mice show reduced numbers of mature β-cells (Sander et al., 2000). 
Hepatocyte nuclear factors (Hnfs) also affect the development of the endocrine pancreas. 
Hnf1α is positively regulated by Hnf4α, and Hnf4α expression depends on Hnf1α (Dukes et al., 
1998; Boj et al., 2001; Hansen et al., 2002). Hnf1α− and Hnf4α−deficiencies cause a dysfunction 
of the β-cells (Boj et al., 2001). Hnf3α−deficient mice show a reduced level of glucagon 
expression, persistent hypoglycemia, and an impaired insulin secretion leading to starvation (Shih 
et al., 1999a). Hnf1α and Hnf3β regulate the expression of Pdx-1 (Lee et al., 2002; Shih et al., 
2002). Hnf1α, Hnf3β and Pdx-1 have been suggested to be the crucial components of the 
pathway for normal insulin secretion and the islet architecture (Shih et al., 2002). 
Hnf3β−deficient mice have a dysregulated insulin secretion and defects in the formation of 
endoderm (Sund et al., 2001). Hnf6-deficient mice have a normal exocrine pancreas but the 
endocrine cell differentiation is delayed and the number of the endocrine cells is reduced 
(Jacquemin et al., 2000). Hnf6 has been found to regulate neurogenin-3 expression, which is 
important for the development of the endocrine cells (Jacquemin et al., 2000). 
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Factor Phenotype Expression 
in embryos 
Expression in  
adults 
Reference 
PDX-1 (-/-) 
 
β-cell specific 
(-/-) 
agenesis of the pancreas 
 
reduced numbers of β-cells, 
reduced insulin expression, 
diabetes   
pancreatic 
precursors 
β-cells (Ahlgren et al., 1996; 
Offield et al., 1996; 
Ahlgren et al., 1998) 
Neurogenin-3 
(-/-) 
Loss of endocrine cells, impaired 
acinar polarity 
endocrine 
progenitors 
islets by RT-PCR (Gradwohl et al., 2000; 
Gu et al., 2002) 
Islet-1 (-/-) Loss of islet cells and dorsal 
mesenchyme, failure of dorsal 
exocrine cell differentiation 
endocrine cells, 
dorsal 
mesenchyme 
endocrine cells (Ahlgren et al., 1997) 
Pax6 (-/-) Reduced number of islet cells 
and reduced hormone expression 
endocrine cells endocrine cells (Sander et al., 1997;  
St-Onge et al., 1997) 
Pax4 (-/-) Loss of β- and δ-cells pancreatic 
precursors 
no or low 
expression mainly 
in the β-cells 
(Sosa-Pineda et al., 
1997) 
Beta2/ 
NeuroD (-/-) 
Reduced numbers of islet cells, 
loss of mature islets, diabetes, 
secretion defects in acinar cells 
endocrine cells endocrine cells (Naya et al., 1997) 
Nkx2.2 (-/-) Reduced numbers of  
α-, β-, and PP-cells, no insulin 
i
pancreatic 
precursors 
α-, β-, and PP- 
cells 
(Sussel et al., 1998) 
Nkx6.1 (-/-) Reduced numbers of mature β-
cells 
pancreatic 
precursors 
β-cells (Sander et al., 2000) 
Hb9 (-/-) Loss of dorsal pancreas, effect 
on endocrine differentiation in 
ventral pancreas 
pancreatic 
precursors 
β-cells (Li et al., 1999) 
P48 (-/-) 
 
Loss of exocrine pancreas, 
an abnormal spatial localisation 
of endocrine pancreas 
pancreatic 
precursors 
exocrine cells (Krapp et al., 1998) 
Hnf1α (−/−) Impaired insulin response pancreatic cells β-cells (Dukes et al., 1998; Boj 
et al., 2001) 
Hnf3α/Foxa1 
(-/-) 
reduced glucagon expression, 
impaired insulin secretion 
early endoderm endocrine cells (Shih et al., 1999a) 
Hnf3β/Foxa2 
β-cell specific 
(-/-) 
impaired insulin secretion and 
formation of endoderm 
pancreatic 
progenitors, 
early endoderm 
pancreatic cells (Sund et al., 2001) 
Hnf6 (-/-) impaired endocrine cell 
differentiation, reduced numbers 
of endocrine cells 
pancreatic 
progenitors 
pancreatic cells (Jacquemin et al., 2000) 
 
Table 1. Summary of the pancreatic phenotypes of the transgenic mice of the transcription factors 
that have a described function in the development of the endocrine pancreas of the mouse. Modified 
from Edlund (2002). 
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2. The kidney 
 
2.1. Overview of the kidney and the glomerular filtration barrier 
 
The kidneys are paired bean-shaped organs located retroperitoneally. The central functions of the 
kidneys are production of urine and regulation of water, electrolyte, acid-base balance, blood 
pressure, and secretion of hormones (Tisher and Madsen, 1991; Clapp and Croker, 1997). The 
nephron is a functional unit of the kidneys and consists of the glomerulus, an organised bunch of 
capillary loops surrounded by the Bowman’s capsule, and the associated tubulus with a distinct 
proximal and distal part. The primary urine is produced in the glomerulus by filtration. Water, 
ions, waste products of the body, and other solutes pass through the glomerular filtration barrier 
into the Bowman’s capsule and further to the associated tubulus where the primary urine is 
modified by reabsorption and secretion. The tubular part of the nephron is connected to the 
collecting duct tree draining to the renal pelvis, and subsequently via the ureter into the urinary 
bladder.  
 
The glomerular filtration barrier is three-layered (Figure 4) and filtration is suggested to be size-, 
charge- and shape-selective (Bohrer et al., 1978; Brenner et al., 1978; Kanwar, 1984; Remuzzi 
and Remuzzi, 1994). The innermost layer of the filtration barrier consists of the vascular 
endothelium. The endothelium has openings up to ~100 nm in width (Tisher and Madsen, 1991). 
The middle layer, the glomerular basement membrane (GBM), ~300 nm in thickness is composed 
of an extracellular matrix produced both by the endothelial cells and podocytes (Sariola et al., 
1984) and contains a network of type IV collagens, laminins, nidogen-1, and heparin sulphate 
proteoglycans creating a negative charge for the GBM, and thereby favouring filtration of 
cationic proteins (Bohrer et al., 1978; Brenner et al., 1978; Kanwar, 1984; Kanwar et al., 1991). 
The podocytes (the visceral epithelial cells) form around the GBM a tight but dynamic web, the 
outermost layer of the filtration barrier (Tisher and Madsen, 1991; Clapp and Croker, 1997). The 
foot processes of adjacent podocytes are linked together with a zipper-like intercellular junction 
structure, a slit diaphragm, allowing passage of small molecules but preventing leakage of large 
molecules to urine (Rodewald and Karnovsky, 1974).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Cross-section of the glomerular filtration barrier. The glomerular filtration barrier is 
composed of three distinct layers: (1) the porous endothelial cell layer, (2) the GBM with its three layers 
and (3) the podocyte layer. The specialised cell junctions, (4) slit diaphragms located between the foot 
processes of adjacent podocytes form an intercellular bridge. The primary urine is filtered through the 
glomerular filtration barrier into the Bowman’s capsule (urinary space).      
1
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2.2. Overview of kidney development 
 
The development of the kidney has three distinct stages: the pronephros, the mesonephros, and 
the metanephros (for a review, see Saxen, 1987). In mammalians, the pronephros and the 
mesonephros exist transiently, while the metanephros represents the permanent kidney. In the 
stage of the pronephros, isolated very primitive “glomeruli” bud from the coelomic (embryonic 
cavity) epithelium. Their lateral ends fuse and form caudally extending the pronephric duct. Its 
epithelium and the predetermined mesonephogenic mesenchyme interact leading to the 
development of the mesonephros with distinct parts of the prospective glomerulus, proximal, 
distal and collecting tubulus connected to the mesonephric Wolffian duct. The induced epithelial 
cells of this nephric duct form the ureteric bud, which grows, branches, and invades into the loose 
metanephogenic mesenchyme (Sorokin and Ekblom, 1992). The epithelial cells of the proximal 
and distal tubules and glomeruli originate from the mesenchyme by a mesenchyme-to-epithelium 
conversion induced by reciprocal interactions between the mesenchyme and ureteric bud. The 
induced mesenchyme condensates around the tips of the ureteric bud, branches, and transforms 
into an epithelial renal vesicle that adopts a comma- and then S-shaped form (Figure 5). At the S-
shaped stage, characterised by the presence of an upper and lower cleft, the area of the future 
glomerulus, proximal and distal tubulus can be distinguished. The tubular parts elongate. The 
glomerulus forms around the lower cleft into which a capillary enters, branches, and forms a 
bunch of capillary loops. Thereafter, glomeruli fold into their mature form.     
 
Despite plenty of knowledge of various transcription and growth factors as well as diverse 
components of the ECM implicated in renal development, the understanding of the exact 
molecular interplay has remained rather disconnected. Important players include for instance: 
The transcription factor encoded by Wilm’s tumor suppressor gene 1 (Wt-1), expressed in 
metanephric blastema (loose mesenchyme that forms nephrons), has been shown to be crucial in 
the early differentiation events of the metanephric kidney (Armstrong et al., 1993; Kreidberg et 
al., 1993). Paired box 2 (Pax-2), regulated by Wt-1, and eyes absent 1 (Eya-1) transcription 
factors have been suggested to participate in the initiation of kidney morphogenesis by 
controlling the expression of glial-cell-line-derived neurotrophic factor (GDNF) which is 
involved in the induction, outgrowth, and branching of the ureteric bud and has been proposed to 
act via the tyrosine kinase receptor Ret and glial-cell-line derived neurotrophic factor 
receptor-α1 (GFRA1) (Sariola and Sainio, 1997). Other factors implicated in the growth and 
branching of the ureteric bud include bone morphogenetic protein 4 (Bmp-4), pleiotrophin, 
proteoglycans and some members of the FGF and Wingless (Wnt) families, like FGF7 and 
Wnt-11 (Vainio and Lin, 2002). Reciprocal interactions between the growing ureteric bud and 
mesenchyme trigger the transition of the metanephric mesenchyme into the epithelium (Saxen, 
1987). Factors expressed in the ureteric bud, such as leukemia inhibitory factor (LIF) and other 
interleukin-6 cytokines have been found to be able to induce epithelialisation of the mesenchymal 
cells (Barasch et al., 1999). Wnt-4 appears to be required for tubulogenesis. Wnt-6 expressed in 
the tips of the ureteric bud has been suggested to activate Wnt-4, and Bmp-7 and Wnt-4 seems to 
be needed for the maturation of the nephron (Sariola and Sainio, 1997; Stark et al., 1994; Vainio 
and Lin, 2002).  
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Figure 5: Scheme of the development of the kidney. (1) In the mouse, on E10.5 the ureteric bud bulges 
from the epithelium of the mesonephric duct. Signals from the loose mesenchyme make the ureteric bud 
(dark grey) to grow. (2) Signals from the growing ureteric bud induce to the loose mesenchyme to 
condense. Reciprocal interactions between the condensing mesenchyme and ureteric bud direct 
mesenchyme-to-epithelial conversion (not shown) and the branching of the growing ureteric bud from 
E11.5 onwards. (3) A renal vesicle forms, (4) adopts a comma-shape and then (5-6) a S-shaped form. A 
capillary enters into the lower cleft (the future glomerulus) (G) and branches. The proximal (P) and distal 
(D) tubular parts elongate and become connected to the collecting duct system (C) formed by the branched 
ureteric bud (6). Some molecules of the nephrogenic and ureteric bud pathways are shown. Modified from 
Saxen (1987), Horster et al. (1999), Vainio and Lin (2002). Abbreviations: PDGF, platelet derived growth 
factor, PDGF-R, PDGF-receptor. 
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Both Pax-2 and Wt-1 have been proposed to be involved in the regulation of the expression of 
nephrin mRNA. Pax-2 has been speculated to act as a repressor of the expression of nephrin 
(Wong et al., 2000) while a reduction of Wt-1 has been shown to downregulate nephrin mRNA 
(Guo et al., 2002). Pax-2 is downregulated at the S-shaped body stage (Dressler and Douglass, 
1992) while nephrin is first detected at the late S-shaped body stage (Ruotsalainen et al., 2000). 
Wt-1 remains to be expressed at the comma- and S-shaped stage followed by downregulation 
elsewhere in the kidney, except in the podocytes (Dressler and Douglass, 1992), the expression 
site of nephrin in the kidney (Holthofer et al., 1999; Holzman et al., 1999; Ruotsalainen et al., 
1999). The transcription factors Pod-1 and Lmx1b are expressed at the S-shaped stage (Sadl et 
al., 2002). The transition from the S-shaped stage to the capillary loop stage includes changes in 
the GBM (Sadl et al., 2002).  Lmx1b appears to affect the regulation of the GBM components α3 
and α4 chains of type IV collagen and the podocyte proteins CD2AP and podocin, and possibly 
nephrin and synaptopodin (Hamano et al., 2002; Miner et al., 2002; Rohr et al., 2002). Pod-1 is 
required for the proper development of the podocyte foot processes (Quaggin, 2002). The 
transcription factor Kreisler has been suggested to work downstream of Pod-1 in the transition 
from the capillary loop stage to the mature stage (Sadl et al., 2002).  
 
 
3. Nephrin and congenital nephrotic syndrome of the Finnish type 
 
The incidence of congenital nephrotic syndrome of the Finnish type (CNF, NPHS1, MIM 
256300) is considerably higher (~0.01% of all births) in Finland than in other countries and CNF 
belongs to the Finnish disease heritage (Rapola, 1987; Norio and Rapola, 1989; Suren et al., 
1993). CNF is a recessively inherited disease manifesting with intrauterine severe proteinuria and 
at birth nephrotic syndrome consisting of proteinuria, hypoalbuminemia, and edema. 
Microscopically CNF is characterised with effaced foot processes of the kidney podocytes, 
proliferation of mesangial cells, fibrosis in kidney glomeruli, and dilated kidney tubules 
(Huttunen et al., 1980; Rapola, 1987; Norio and Rapola, 1989; Suren et al., 1993). Untreated 
CNF is lethal but can be treated with renal transplantation (Rapola, 1987). The defective gene in 
CNF was first located to the chromosome locus 19q13.1 (Kestila et al., 1994; Mannikko et al., 
1995), finally discovered with positional cloning, and named as NPHS1 (Kestila et al., 1998). 
Since then, several mutations of the NPHS1 gene have been found but two of them, Finmajor and 
Finminor, account for over 90 % of CNF cases in Finland (Kestila et al., 1998). Finmajor is a 2 bp 
deletion in exon 2 and Finminor a nonsense mutation in exon 26 – both resulting in a translation 
stop codon (Kestila et al., 1998) and subsequently, absence of the protein product, nephrin 
(Holthofer et al., 1999; Patrakka et al., 2000; Ruotsalainen et al., 2000). Nephrin was localised at 
the interpodocyte slit diaphragm between the podocyte foot processes (Holthofer et al., 1999; 
Holzman et al., 1999; Ruotsalainen et al., 1999), which supports the role of nephrin as a key 
protein of the glomerular filtration barrier at the slit diaphragm (Tryggvason, 1999; Tryggvason 
et al., 1999).  
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Figure 6. The NPHS1 gene and its protein product, nephrin. The gene has 29 exons encoding a 4.3 kb 
mRNA. Exon 1 encodes a signal peptide, exons 2-20 Ig-like domains, exons 22-23 a fibronectin-type III 
(FN) domain, exon 24 a transmembrane region (TMR), and exons 25-29 the intracellular part. The 
locations of the most common mutations of the gene in Finland (Finmajor and Finminor) are marked. 
 
 
The size of the human NPHS1 gene is ~26 kb (Kestila et al., 1998; Lenkkeri et al., 1999). The 
promoter of the NPHS1 gene has several potential binding sequences for diverse transcription 
factors, for example, GATA-1, GATA-2, NF-1, AP2, AP4, Ets-1, NFAT, deltaEF1, MZF1, and 
Pax-2 (Lenkkeri et al., 1999; Moeller et al., 2000; Wong et al., 2000; Beltcheva et al., 2003). Pax-
2 has been speculated to act as a repressor of the NPHS1 gene (Wong et al., 2000). The gene 
contains 29 exons producing an approximately 4.3 kb mRNA (AF035835) encoding the nephrin 
protein (Kestila et al., 1998; Lenkkeri et al., 1999). In detail, the signal peptide is coded by exon 
1, eight immunoglobulin-like (Ig-like) domains coded by exons 2-20 and a fibronectin type III 
domain coded by exons 22-23 (Lenkkeri et al., 1999). Exon 24 encodes a transmembrane region, 
and exons 25-29 code for the intracellular domain. The sequence-based calculated molecular 
weight of the 1241 amino acid nephrin is ~135 kDa but as proposed due to mainly N-
glycosylation, the reported molecular weight is ~185-200 kDa (Kestila et al., 1998; Ahola et al., 
1999; Holthofer et al., 1999; Holzman et al., 1999; Yan et al., 2002). Besides the full-length 
mRNA, the human NPHS1 gene encodes an alternatively spliced mRNA, α-nephrin, lacking the 
sequence for the transmembrane region (exon 24) raising a possibility for a secreted form of 
nephrin (Holthofer et al., 1999). Rat nephrin has also been shown to exhibit several splice 
variants (Ahola et al., 1999). Recently, mouse nephrin has also been found to exhibit a tissue-
specific alternative splicing (Beltcheva et al., 2003). The amino acid sequence of rat (Ahola et al., 
1999; Kawachi et al., 2000) and mouse nephrin (Holzman et al., 1999; Putaala et al., 2000) shows 
greater than 80 % identity to human nephrin, and the overall pattern of the signal sequence, Ig-
like domains, fibronectin type III-like module, transmembrane region, most sites of cysteines, 
tyrosines and potential glycosylation are conserved (Ahola et al., 1999; Holzman et al., 1999; 
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Kawachi et al., 2000; Putaala et al., 2000). Even in the nephrin related gene of Caenorhabditis 
elegans and Drosophila, the domain structure has been found to be rather conserved (Teichmann 
and Chothia, 2000; Dworak et al., 2001).  
 
Functions of nephrin are not yet thoroughly known. Due to the Ig-like modules nephrin has been 
included into the immunoglobulin superfamily (Kestila et al., 1998), the members of which are 
typically involved in cell-cell or cell-matrix adhesion, signalling or migration (Brummendorf and 
Rathjen, 1994; Juliano, 2002). The absence of nephrin in CNF, leading to massive proteinuria 
(Kestila et al., 1998; Ruotsalainen et al., 2000), and downregulation of nephrin in other 
proteinuric syndromes (Furness et al., 1999; Doublier et al., 2001; Srivastava et al., 2001; Kim et 
al., 2002; Wang et al., 2002) and experimental models of proteinuria (Kawachi et al., 2000; 
Luimula et al., 2000a; Luimula et al., 2000b; Yuan et al., 2002b) indicate the importance of 
nephrin in sustaining the functional interpodocyte slit membrane and the glomerular filtration 
barrier. The functions of the splice variants of nephrin (Ahola et al., 1999; Holthofer et al., 1999; 
Beltcheva et al., 2003) are unknown but the expression of α-nephrin in puromycin nephrosis 
seems to follow the expression pattern of the full length mRNA (Luimula et al., 2000a).  
 
Nephrin has also been suggested to participate in cell signalling via tyrosine residues in its 
intracellular domain (Kestila et al., 1998). In addition, the sequence contains two protein kinase 
C phosphorylation sites (Ser/Thr-X-Arg/Lys) (Putaala et al., 2000). The first evidence of the 
signalling function was achieved by showing that nephrin associates with signalling 
microdomains, lipid rafts, where phosphorylation of nephrin could be induced (Simons et al., 
2001). Later, activation of protein kinase C, a family of serine/threonine kinases, was shown to 
upregulate the expression of nephrin (Wang et al., 2001a). An overexpression of nephrin in vitro 
was found to stimulate the stress-activated p38 protein kinase and c-jun aminoterminal kinase 
involved in the regulation of the formation of Activator Protein-1 (AP-1), and the activation of 
these pathways was facilitated by the interaction of nephrin with podocin (Huber et al., 2001). In 
addition, the presence of Wt-1 has been found to regulate nephrin suggesting that nephrin acts 
downstream of Wt-1 (Guo et al., 2002). Decreased levels of Wt-1 have been found to 
downregulate nephrin. 
 
In contrast to reduced levels of nephrin typically found in various proteinuric syndromes (Furness 
et al., 1999; Kawachi et al., 2000; Luimula et al., 2000a; Luimula et al., 2000b; Doublier et al., 
2001; Srivastava et al., 2001; Kim et al., 2002; Wang et al., 2002; Yuan et al., 2002b)1 expression 
of nephrin mRNA was found to be increased in experimental models of diabetic nephropathy 
during the early follow-up period of 16 weeks (Aaltonen et al., 2001). Later, at 6 months nephrin 
expression was found to be reduced (Bonnet et al., 2001; Kelly et al., 2002). In addition, a more 
punctate distribution of nephrin in the glomeruli, and free nephrin in urine could be detected 
(Aaltonen et al., 2001). Loss of nephrin to urine (Luimula et al., 2000a), relocalisation of nephrin 
and an alteration of the typical fine granular linear immunoreactivity of nephrin into a punctate 
pattern have also been reported in the podocytes (Kawachi et al., 2000; Luimula et al., 2000b; 
Doublier et al., 2001; Huh et al., 2002; Yuan et al., 2002b). Interestingly, the changes in the level 
and localisation of nephrin could be prevented by blocking the renin angiotensin system (Benigni 
et al., 2001; Bonnet et al., 2001; Cao et al., 2002; Kelly et al., 2002; Langham et al., 2002). In 
addition, the nephrin redistribution could be affected with agents acting on actin microfilaments 
indicating their involvement (Doublier et al., 2001; Saleem et al., 2002).   
 
                         
1
 No expression changes of nephrin were detected in pediatric acquired nephrotic syndromes 
with in situ hybridisation (ISH) and immunohistochemistry (Patrakka et al., 2001). 
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During mouse morphogenesis nephrin mRNA was present in the podocyte-like structures of the 
mesonephric kidney but it was not detected by ISH in the mesenchyme of the developing E11 
metanephric kidney (Putaala et al., 2000). The comma- and early S-shaped bodies were negative 
for nephrin mRNA (Putaala et al., 2000) and protein (Holzman et al., 1999; Li et al., 2000). 
Nephrin mRNA was first detected in the late S-shaped bodies (Wong et al., 2000) and the E13 
podocytes (Putaala et al., 2000) while the protein was observed at the capillary loop stage and in 
the mature glomeruli (Holzman et al., 1999; Li et al., 2000). In the rat, nephrin mRNA could not 
be detected by reverse transcriptase-polymerase chain reaction (RT-PCR) in the E13.5 or E15.5 
kidneys while the E18.5 kidney showed a clear signal (Kawachi et al., 2000). In the human fetal 
kidney, nephrin mRNA and protein were seen in the late S-shaped bodies by ISH and 
immunohistochemistry (Ruotsalainen et al., 2000).  
 
Originally nephrin was suggested to be podocyte-specific as Northern blotting did not detect 
nephrin mRNA in other tissues (Kestila et al., 1998). By immunofluorescence, immunoreactivity 
for nephrin was not detected in extrarenal tissues studied including the pancreas, spleen, and 
cerebellum (Kawachi et al., 2000). More recently, nephrin promoter activity and the presence of 
nephrin mRNA were reported in the developing central nervous system (CNS) and pancreas in 
the mouse (Moeller et al., 2000; Putaala et al., 2000; Wong et al., 2000; Putaala et al., 2001; 
Moeller et al., 2002; Beltcheva et al., 2003). Comparison of the nephrin promoter sequences 
different in length revealed that their ability to drive nephrin expression in different tissues varied 
suggesting a tissue-specific regulation of the gene (Moeller et al., 2000; Wong et al., 2000; 
Eremina et al., 2002; Moeller et al., 2002). This and tissue-specific alternative splicing were 
verified recently (Beltcheva et al., 2003). In the CNS, nephrin expression was found for instance 
in the spinal cord, cerebellum, mesencephalon, and olfactory bulb (Moeller et al., 2000; Putaala 
et al., 2000; Putaala et al., 2001). Besides the kidney, CNS, and pancreas, nephrin expression has 
been reported in the spleen (Ahola et al., 1999). Functions of nephrin are unknown in these 
extrarenal locations. 
 
 
4. Suggested members of the nephrin-associated protein complex 
 
The slit diaphragm appears to be a modified adherens junction (Reiser et al., 2000; Pavenstadt et 
al., 2003). For a long time the only identified component of the protein complex of the slit 
diaphragm in the glomerular filtration barrier was zonula occludens-1 (ZO-1) (Schnabel et al., 
1990; Kurihara et al., 1992). The discovery of nephrin as a central component of the slit 
diaphragm (Kestila et al., 1998), however, facilitated the identification of other potential proteins 
in the slit diaphragm associated complex. By now, CD2-associated protein (CD2AP) (Shih et al., 
1999), podocin (Boute et al., 2000a; Roselli et al., 2002b), P-cadherin (Reiser et al., 2000), α-
actinin-4 (Kaplan et al., 2000), synaptopodin (Shih et al., 1999b; Schwarz et al., 2001), FAT 
(Inoue et al., 2001), and densin (unpublished) have been localised in the slit diaphragm area, to 
the vicinity of nephrin in the podocytes or found to be critical for glomerular filtration function. 
In addition, a novel, structurally nephrin-related NEPH protein family has been discovered 
(Donoviel et al., 2001; Sellin et al., 2002). 
 
 
 
 
 
 
 24 
 
Gene Observed phenotype Reference 
Nephrin (-/-) severe proteinuria, effaced podocyte foot processes (Putaala et al., 2001) 
CD2AP (-/-) severe proteinuria, T-cell, splenic, thymic, heart defect (Shih et al., 1999b) 
Podocin (-/-) severe proteinuria, mesangial sclerosis (Roselli et al., 2002a) 
P-cadherin (-/-) hyperplastic and dysplastic epithelium in 
mammary glands with lymphocyte infiltration  
(Radice et al., 1997b) 
Alpha-actinin-4* proteinuria, glomerulosclerosis, dilated tubules (Michaud et al., 2002) 
Synaptopodin (-/-) reduced adaptation to glomerular stress  (Giardino et al., 2002) 
NEPH1 (-/-) severe proteinuria, effaced podocyte foot processes (Donoviel et al., 2001) 
 
Table 2. The phenotypes of the transgenic mice of the selected podocyte proteins.  *The transgenic 
mice overexpress α-actinin-4 that has a mutation analogous to that found in human familial focal 
segmental glomerulosclerosis.  
 
 
The transgenic mice for some of the above mentioned podocyte proteins have been created, and 
their phenotypes have been characterised (Table 2). By now, nephrin-, CD2AP-, podocin-, 
NEPH1-deficient mice have been reported to show severe proteinuria confirming their 
importance for the functional glomerular filtration barrier. In addition, the α-actinin-4 and 
synaptopodin transgenic mice have been found to exhibit an abnormal kidney phenotype. 
Interestingly, no kidney defects have been reported for P-cadherin-deficient mice. The 
characterisation of these transgenic mice has been nearly completely restricted to the kidney, and 
no reports of other tissue defects have been published. However, in case of CD2AP-deficient 
mice, T-cell, splenic, thymic, heart defects, and ascites have also been reported (Shih et al., 
1999b). No other abnormalities have been observed although CD2AP is widely expressed 
(Dustin et al., 1998; Kirsch et al., 1999). NEPH1-deficient mice have also failed to demonstrate 
extrarenal abnormalities (Donoviel et al., 2001). Subtle phenotypes or redundancy could explain 
lack of a clear loss-of-function phenotype. Alternatively, the early lethality of these mice may 
hamper the revelation of the extrarenal phenotypes.  
 
Despite the recent progress, the molecular composition of the nephrin-associated protein complex 
is not fully clarified. The characterisation of the intermolecular relations of the known proteins 
involved, their links to the cell cytoskeleton and their participation in signalling pathways are 
under an intensive study. The nephrin interacting protein complex in other tissues expressing 
nephrin is unstudied.  
 
 
4.1. CD2AP 
 
CD2AP was named after its T-cell interaction partner, CD2, an adhesion protein participating in 
antigen recognition at the contact area between T-cell and antigen presenting cell. In T-cells 
CD2AP was found to stabilise the interaction with antigen presenting cell by enhancing CD2 
clustering and organising the cytoskeleton around the interaction site needed for the polarisation 
of T-cells (Dustin et al., 1998).  
 
Besides an affected immune system, CD2AP-deficient mice were found to be proteinuric which 
suggested that CD2AP is needed for the functional glomerular filtration barrier. Subsequent 
studies showed that CD2AP can be found in the close vicinity of the slit diaphragm (Shih et al., 
2001), and coimmunoprecipitations with the overexpressed CD2AP and intracellular domain of 
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nephrin suggested a physical interaction (Shih et al., 1999b). Further studies, however, provided 
controversial data either not supporting (Huber et al., 2001) or supporting the interaction between 
nephrin and CD2AP (Shih et al., 2001).  
 
Besides CD2 and nephrin, CD2AP has been shown to bind polycystin-2 (Lehtonen et al., 2000), 
the focal adhesion protein p130CAS, Src-family tyrosine kinases, the p85 subunit of 
phosphatidylinositol 3 kinase, Grb2 (Kirsch et al., 1999), c-Cbl (Kirsch et al., 2001), and actin 
(Lehtonen et al., 2002). In addition, CD2AP have been found to colocalise with the podocyte foot 
process marker, synaptopodin (Shih et al., 1999), as well as to reside close to α-actinin-4 in the 
cultured podocytes (Welsch et al., 2001).  
 
CD2AP (a.k.a mesenchyme-to-epithelium transition protein with SH 3 domains/METS/Cas 
ligand with multiple SH 3 domains/CMS) is a ~80-kDa protein with three aminoterminal SH 3 
domains, followed by a proline-rich area, a coiled-coil region, dimerisation sequence and an 
actin-binding site at the carboxy terminus (Dustin et al., 1998; Kirsch et al., 1999; Lehtonen et 
al., 2000). CD2AP is expressed in several tissues, including the kidney (Kirsch et al., 1999; Shih 
et al., 1999b). During morphogenesis of the kidney, a weak expression of CD2AP can be detected 
in undifferentiated metanephric mesenchyme (Lehtonen et al., 2000). In the developing 
glomerulus CD2AP is clearly detected at the capillary loop stage, and in the mature kidney it is 
expressed strongly in the glomerular podocytes and cortical collecting ducts (Shih et al., 1999b; 
Lehtonen et al., 2000; Li et al., 2000). CD2AP has been suggested to act as an adapter, which 
links a variety of membrane proteins, such as CD2 and nephrin to the cytoskeleton (Dustin et al., 
1998; Lehtonen et al., 2002; Saleem et al., 2002; Yuan et al., 2002a).  
 
 
4.2. Podocin 
 
The NPHS2 human podocin gene has been mapped to 1q25-31 and found to cause a recessive 
steroid-resistant nephrotic syndrome with an early onset and quick progression to end-stage renal 
disease and focal segmental glomerulosclerosis suggesting a role for podocin in the glomerular 
permeability (Boute et al., 2000a). Podocin is a 42-kDa integral membrane protein of the band-7-
stomatin protein family, and it exhibits 47 % identity with human stomatin (Boute et al., 2000). 
Podocin is expressed mainly in the glomerular podocytes and to a lesser extent in the testes, fetal 
heart and liver (Boute et al., 2000a). During kidney morphogenesis podocin mRNA is seen at the 
late S-shaped body stage, and the expression is sustained in the mature kidney (Boute et al., 
2000a). In the podocytes podocin has been localised in the slit diaphragm area (Schwarz et al., 
2001; Roselli et al., 2002b), and like nephrin and CD2AP, shown to associate with lipid rafts 
(Schwarz et al., 2001; Simons et al., 2001). The proline-rich carboxy terminus of podocin has 
been found to mediate the interactions with CD2AP, nephrin (Schwarz et al., 2001), NEPH1, 
NEPH2, and NEPH3 (Sellin et al., 2002). The intracellular amino acids 1160-1241 of nephrin 
(Huber et al., 2001) and the intracellular Pro-X-X-X-Tyr motif of NEPH1 (Sellin et al., 2002) 
have been found to be important for the respective interactions with podocin. The proline and 
tyrosine residues of the motif are conserved in NEPH1, NEPH2, NEPH3 and nephrin (Sellin et 
al., 2002). Podocin also appears to form oligomers (Schwarz et al., 2001). The interaction 
between CD2AP and podocin was proposed to be limited to a monomeric form of podocin 
(Schwarz et al., 2001). Another study failed to show an interaction between CD2AP and podocin 
but verified the interaction between podocin and nephrin (Huber et al., 2001). 
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Podocin has been shown to augment nephrin signalling via mitogen activated protein kinase 
signalling by activating p38 and c-jun aminoterminal kinase involved in the regulation of the 
formation of AP-1, that affects its target genes (Huber et al., 2001). Recently, it was also shown 
that lack of the transcription factor Lmx1b results in reduced levels of CD2AP and podocin, 
(Hamano et al., 2002; Miner et al., 2002; Rohr et al., 2002) suggesting the involvement of Lmx1b 
in the regulation of podocin and CD2AP. 
 
 
4.3. Alpha-actinin-4 
 
Alpha-actinin-4 is a 100-kDa protein with an aminoterminal actin crosslinking site, a middle 
domain of spectrin-like repeats and a carboxyterminal calcium-binding domain (Honda et al., 
1998; Goto et al., 2003). Alpha-actinin-4 mRNA is expressed in several tissues, including the 
pancreas and kidney (Honda et al., 1998). In the kidneys, α−actinin-4 is found in the walls of 
blood vessels and podocytes, potential sites for affecting haemodynamics and regulating 
glomerular filtration (Smoyer et al., 1997; Kaplan et al., 2000). Subcellularly, α-actinin-4 has 
been found to partially colocalise with actin stress fibers, translocate into the nucleus upon 
depolymerisation of actin (Honda et al., 1998), reside near CD2AP (Welsch et al., 2001) and 
associate with the tight juction protein MAGI-1 (membrane associated guanylate kinase with an 
inverted domain organisation) (Patrie et al., 2002). In addition, α-actinin-4 is present in the 
cytoplasm and at the leading edge of extending cells while absent at the focal adhesion plaques, 
which are the localisation sites of alpha-actinin-1 (Honda et al., 1998). Alpha-actinin has been 
found to mediate the interaction of the cadherin/catenin complexes and the actin cytoskeleton via 
α-catenin (Knudsen et al., 1995). In the model of molecular organisation of the podocyte α-
actinin-4 has been speculated to link the protein complex of the slit diaphragm and the basal 
protein complexes to the actin cytoskeleton (Somlo and Mundel, 2000). 
 
The ACTN4/FSGS1 gene on chromosome 19q13 has been found to be mutated in dominant focal 
segmental glomerulosceloris characterised by adult onset and slow progression (Kaplan and 
Pollak, 2001; Kaplan et al., 2000). The reported missense mutations reside in the actin-binding 
region strengthening the actin-binding capacity of the ACTN4 variants (Kaplan et al., 2000). 
Other findings also propose an involvement of the actin cytoskeleton in the pathogenesis of 
proteinuria. Upregulation of ACTN4 has been found to precede the effacement of the podocyte 
foot processes in an experimental nephrotic syndrome induced by puromycin amino nucleoside 
(Smoyer et al., 1997). It has been observed to bind the central part of α-actinin-4, which may 
interfere interactions mediated by that area (Goto et al., 2003). However, this binding was not 
found to affect the binding activity of α-actinin-4 to actin. 
 
 
4.4. NEPH protein family 
 
The NEPH protein family consists of NEPH1, NEPH2 and filtrin (NEPH3) and is suggested to 
participate in cell adhesion and signalling (Donoviel et al., 2001; Ihalmo et al., 2002; Sellin et al., 
2002). The NEPH proteins are related with a  ~20 % identity between NEPH1 and NEPH2 and a 
~14 % identity between NEPH1 and NEPH3 (Sellin et al., 2002). In addition, the family shares a 
common structure of five extracellular Ig-like modules, an integrin recognition site, a 
transmembrane sequence, and an intracellular part with a Grb2-SH2 and PDZK1 binding site, 
and a podocin-interacting motif (Donoviel et al., 2001; Ihalmo et al., 2002; Sellin et al., 2002). 
All three NEPH proteins have been shown to interact with podocin and ZO-1, and NEPH1 also 
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with Grb-2 and PDZK1 (Sellin et al., 2002; Huber et al., 2003). The Grb2-SH2 site suggests an 
involvement in signalling, and like nephrin, NEPH1 and NEPH2 have been shown to activate the 
AP-1 mediated transcription (Sellin et al., 2002). NEPH1 signalling was not significantly 
augmented by podocin while Itk or other Tec kinases enhanced the signalling (Sellin et al., 2002). 
The ability of Tec and Src kinases to abolish the interaction between NEPH1 and podocin 
suggests phosphorylation-regulated interaction (Sellin et al., 2002).    
 
Human NEPH1 mRNA encodes a ~67-kDa protein with an 18 % identity with nephrin (Donoviel 
et al., 2001). The NEPH1 gene apparently locates to 1q21-25 (Donoviel et al., 2001). NEPH1 is 
rather widely expressed, including the kidney, spleen, stomach, testis, and heart (Donoviel et al., 
2001). In the newborn mouse kidney, the expression has been localised in the glomerular 
podocytes, mesangium, tubular epithelium, vascular smooth muscle, and endothelium (Donoviel 
et al., 2001). In the podocytes, NEPH1 has been localised in the lateral margins of foot processes 
at the insertion site of the slit diaphragm (Barletta et al., 2003). NEPH1 has been shown to 
heterodimerise with nephrin via their Ig-like domains and intracellular parts (Gerke et al., 2002; 
Barletta et al., 2003). NEPH1-deficient mice exhibit effaced foot processes, proteinuria, and early 
postnatal lethality suggesting its importance for the glomerular filtration barrier (Donoviel et al., 
2001). The respective human disease has not been characterised.  
 
The NEPH2 gene maps to 11q24 and encodes a protein with 778 amino acids.  The sequence-
based calculated molecular weight of NEPH2 is ~86 kDa (Sellin et al., 2002). NEPH2 expression 
has been to found, for instance, in the brain, heart, CNS, and kidney cortex as well as in a 
podocyte cell line (Sellin et al., 2002).  
 
The NEPH3 gene maps to 19q13.1, and encodes a 708 amino acid protein (Ihalmo et al., 2002). 
The promoter areas of the NEPH3 (filtrin) and NPHS1 (NEPHRIN) genes overlap but the genes 
are transcribed to opposite directions (Ihalmo et al., 2002). The estimated sequence-based 
molecular weight of the gene product, filtrin, is ~75 kDa, and by immunoblotting a band of 107 
kDa is detected in the glomeruli (Ihalmo et al., 2002). Besides the full-length filtrin, filtrin-α 
without exon 4 and filtrin-β (~22 kDa in size) without the transmembrane region have been found 
(Ihalmo et al., 2002). Filtrin mRNA has been detected, for instance, in the pancreas, lymph node, 
kidney cortex, brain, and lung as well as in a podocyte cell line (Ihalmo et al., 2002; Sellin et al., 
2002).   
 
 
4.5. Densin 
 
Densin is a 180-kDa member of the LAP (leucine-rich repeats and PSD-95/Dlg-A/ZO-1 (PDZ) 
domains) family. It was originally discovered in the CNS at the postsynaptic density (PSD) 
(Apperson et al., 1996), a fibrous submembrane complex of proteins adhering the postsynaptic 
membrane to the cytoskeleton (Kennedy, 1997). At the synapses densin interacts via its PDZ 
domain with δ-catenin/neural plakophilin-related armadillo repeat protein (NPRAP) (Izawa et al., 
2002). NPRAP, in turn, binds to synaptic scaffolding membrane associated guanylate kinase (S-
SCAM) that interacts with glutamatergic N-methyl-D-aspartate (NMDA) receptors and a cell 
adhesion protein neuroligin (Ide et al., 1999). In addition, densin is able to coimmunoprecipitate 
N-cadherin (Izawa et al., 2002), and to form a complex with MAGUIN-1 (MAGUK interacting 
protein) that binds S-SCAM and PSD-95 as well as self associates (Ohtakara et al., 2002). PSD-
95, a membrane-associated guanylate kinase (MAGUK) is involved in the clustering of NMDA 
glutaminergic receptors. The NMDA receptor interacts and is phosphorylated by 
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calcium/calmodulin dependent protein kinase type II (CaMKII) (Kennedy, 1997, 1998). 
Furthermore, densin has been shown to interact with α-actinin-4 and the α subunit of CaMKII 
(Strack et al., 2000; Walikonis et al., 2001). Autophosphorylation of CaMKII facilitates the 
interaction with densin, and phosphorylation of densin by CaMKII has only a minor negative 
influence on the affinity for CaMKII (Walikonis et al., 2001).  
 
Densin and the densin-associated complex have been implicated in the organisation of the cell 
junction between presynaptic and postsynaptic membranes at glutamatergic synapses (Apperson 
et al., 1996). Originally, densin was suggested to be brain-specific residing at synapses along 
dendrites (Apperson et al., 1996). However, recently the kidney podocytes have been shown to 
express densin. It has been localised at the slit diaphragm and shown to interact with nephrin 
(unpublished results). Interestingly, densin is found both in the CNS and kidney at a specialised 
cell junction namely at the PSD and slit diaphragm, respectively. By now, no human disease has 
been linked to the deficiency of densin. 
 
 
4.6. Synaptopodin 
 
Synaptopodin (pp44) is an actin-associating protein of the podocyte foot processes and the PSD 
of the telencephalic dentrites (Mundel et al., 1991; Mundel et al., 1997a). Synaptopodin has high 
proline content suggesting a linear conformation that can enable a parallel localisation with actin 
(Mundel et al., 1997a). The calculated molecular weight of synaptopodin is ~74 kDa but it 
appears as a ~100-kDa protein in the brain and as a ~110-kDa protein in the kidney glomeruli 
(Mundel et al., 1997a). In the podocytes, synaptopodin is found at the capillary loop stage 
(Mundel et al., 1991), and it colocalises with podocin (Schwarz et al., 2001; Roselli et al., 2002b) 
and CD2AP (Shih et al., 1999b). In addition, synaptopodin, like α-actinin-4, appears to bind to 
MAGI-1 (Patrie et al., 2002). Like nephrin, synaptopodin has been implicated in the formation of 
the structure of the podocytes (Mundel et al., 1991). The association of synaptopodin with actin 
in the podocytes suggests a role in the structural and functional dynamics of the podocyte foot 
processes (Mundel et al., 1997a). Human inherited disorders of synaptopodin gene have not been 
reported although reduced levels of synaptopodin in nephrotic syndromes have been observed 
(Srivastava et al., 2001). This has been concluded as a secondary phenomenon related to 
cytoskeletal rearrangements or proteinuria. 
 
 
4.7. ZO-1 
 
ZO-1 is a widely expressed peripheral membrane protein of intercellular junctions (Mitic and 
Anderson, 1998; Tsukita et al., 2001). In the pancreas, ZO-1 is found in the exocrine pancreas 
(Kleeff et al., 2001). At the early S-shaped body stage of the kidney glomeruli, ZO-1 is already 
present in the apical junctional complexes that slide along the lateral cell membrane near to the 
basal pole of the podocyte (Schnabel et al., 1990). At the capillary loop stage both ZO-1 and 
nephrin are found in the lateral cell membranes at the developing slit diaphragms (Schnabel et al., 
1990; Ruotsalainen et al., 2000). In the mature podocytes, the α- isoform of ZO-1 has been shown 
to reside intracellularly near the insertion sites of the slit diaphragms of the podocytes (Schnabel 
et al., 1990; Kurihara et al., 1992).  
 
Human disorders of ZO-1 gene have not been reported. In the rat, an in vivo injection of the 
monoclonal antibody 5-1-6 (nephrin) (Topham et al., 1999) induces a massive proteinuria and 
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alters the immunoreactivity patterns of nephrin and ZO-1 into more discontinuous suggesting a 
link between nephrin and ZO-1 (Kawachi et al., 1997; Kawachi et al., 2000). Recently, the 
MAGUK protein ZO-1 was found to interact with NEPH1 (Huber et al., 2003) that has been 
shown to interact with nephrin (Barletta et al., 2003). Thus, ZO-1 could link NEPH1 and nephrin 
to the actin cytoskeleton. Previously, in non-epithelial cells ZO-1 has been shown to connect the 
cadherin/catenin complex to the actin cytoskeleton via its interactions with α-catenin and actin 
(Itoh et al., 1997).  
 
 
4.8. Cadherins 
 
The cadherins are a family of transmembrane cell adhesion proteins mediating calcium 
dependent, homophilic, cell-cell adhesion and linking the adherens junctions to the cytoskeleton 
via the cadherin-associated protein complex, including α-, β- and/or γ-catenins, and α-actinin 
(Takeichi et al., 1988; Ozawa et al., 1989; Ozawa et al., 1990; Ozawa and Kemler, 1992; 
Knudsen et al., 1995). P-cadherin has been suggested to be involved in the nephrin-associated 
protein complex (Reiser et al., 2000). P-cadherin has not been reported to play a role in the 
endocrine pancreas but other members of the cadherin family, like E-, N- and R-cadherin are 
found in the endocrine pancreas and could substitute P-cadherin, and therefore are reviewed here. 
No human renal or pancreatic disorders of above mentioned cadherins have been reported.  
 
4.8.1. P-cadherin 
 
During kidney morphogenesis P-cadherin is detected in the ureteric bud, tubules, and glomeruli 
of the vesicle stage (Ruotsalainen et al., 2000). P-cadherin colocalises with nephrin and ZO-1 in 
the late S-shaped glomeruli (Ruotsalainen et al., 2000). In mature glomeruli a significantly 
reduced immunoreactivity of P-cadherin localises near the slit diaphragm area (Reiser et al., 
2000; Ruotsalainen et al., 2000).  
 
Like nephrin, P-cadherin has also been suggested to form the core scaffold of the slit diaphragm, 
a modified adherens junction (Reiser et al., 2000). This cadherin-based junction has been 
suggested to consist of P-cadherin, nephrin, α-, β- and γ-catenins linked via α-actinin or ZO-1 to 
the cell cytoskeleton (Ozawa et al., 1989; Ozawa et al., 1990; Ozawa and Kemler, 1992; Knudsen 
et al., 1995; Itoh et al., 1997; Reiser et al., 2000). NPHS1 kidneys lacking the slit diaphragms and 
the functional filtration barrier express P-cadherin normally (Ruotsalainen et al., 2000), and P-
cadherin-deficient mice have not been reported to be proteinuric (Radice et al., 1997b). These 
findings do not suggest that P-cadherin could be a core protein of the slit diaphragm but may still 
be its component. 
 
4.8.2. E-cadherin 
 
During kidney development, E-cadherin is found in the ureteric bud and S-shaped bodies. After 
that, E-cadherin becomes restricted to the distal tubular epithelial cells with no expression in the 
proximal tubular epithelial cells or podocytes (Nouwen et al., 1993). During pancreatic 
development E-cadherin is important for the clustering of the islet cells and for the formation of 
the islets: islet-like structures consisting of α-cells without β-cells are formed in the mice without 
functional E-cadherin in the β-cells. In these mice N-cadherin is not observed at the cell-cell 
contacts suggesting a role for the functional E-cadherin in the maintenance of cell-cell contacts 
(Dahl et al., 1996).  
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In the mature pancreas, E-cadherin is expressed both in the exocrine and endocrine cells, and it is 
thus suggested to provide the basic cell-type independent intercellular cohesive force between the 
pancreatic cells (Rouiller et al., 1991; Cirulli et al., 1994). Within the islets of Langerhans the β-
cells form the core of the islet while the other endocrine cells are located at the periphery of the 
islet (Orci and Unger, 1975). This organised architecture of the islets has been suggested to 
originate from differential expression of cell adhesion molecules. E-cadherin, however, is 
expressed both in the β- and non-β-cells, and therefore probably does not account for this islet 
cell type segregation (Rouiller et al., 1991).    
 
4.8.3. N- and R-cadherin 
 
During kidney development, R-cadherin is found in the condensing mesenchyme around the tips 
of the ureteric bud. R-cadherin is restricted to the glomerular podocytes at the S-shaped body 
stage followed by more intense immunoreactivity at the capillary loop stage and loss of 
immunoreactivity during the final maturation (Goto et al., 1998; Dahl et al., 2002). N-cadherin 
emerges in the non-induced mesenchyme and is found in the lower limb of the S-shaped body 
and later in the proximal tubules (Nouwen et al., 1993). N-cadherin is not detected thereafter. R-
cadherin-deficient mice show a subtle phenotype with dilated proximal tubules and intracellular 
vacuoli (Dahl et al., 2002) whereas loss of N-cadherin is lethal during embryogenesis (Radice et 
al., 1997a).   
 
N-cadherin-deficient mice exhibit agenesis of the dorsal pancreas showing the necessity of N-
cadherin (Esni et al., 2001) whereas R-cadherin-deficient mice show no obvious pancreatic 
phenotype (Dahl et al., 2002). During pancreatic development, R- and N-cadherin mRNA has 
been found in the early hormone-producing cells in the duct epithelium (Hutton et al., 1993). N- 
and R-cadherin mRNA was found to be enriched in the endocrine pancreas and especially in the 
β-cells (Hutton et al., 1993). This differential expression was suggested to explain the 
segregation of the exocrine and endocrine pancreatic tissue and islet cells (Hutton et al., 1993). 
With antibodies, however, R-cadherin was localised in the early hormone-producing cells and 
duct-like cells on E10.5 (Sjodin et al., 1995). Downregulation of R-cadherin in the intraductule 
endocrine cells was found, and it was suggested to correlate to their migration into the pancreatic 
mesenchyme (Sjodin et al., 1995). In mature islets, R-cadherin was not detected while it was 
reported to be present in the exocrine acinar and ductal cells (Sjodin et al., 1995). Later, low 
levels of R-cadherin have been found in the cytoplasm of the β-cells (Esni et al., 1999). N-
cadherin appears to be expressed in the islets cells and in the exocrine pancreas (Cirulli et al., 
1994; Esni et al., 1999). 
 
4.8.4. FAT  
 
FAT, a giant relative of the cadherins, has extracellular 34 cadherin-like repeats, five EGF-like 
repeats and a laminin A G domain, a transmembrane region and an intracellular part (Dunne et 
al., 1995). The molecular weight of FAT is over 500 kDa (Inoue et al., 2001). FAT was first 
found in Drosophila and implicated in morphogenesis and cell proliferation as a tumor 
suppressor gene (Mahoney et al., 1991). During morphogenesis, FAT is widely expressed, 
especially in epithelial cell regions and CNS, while adult tissues typically lack or show low levels 
of FAT (Dunne et al., 1995; Ponassi et al., 1999). Recently, FAT was found in the podocytes, 
parietal epithelial cells, distal and collecting tubular epithelial cells, and endothelial cells (Inoue 
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et al., 2001). In podocytes, FAT was colocalised with ZO-1 and the 5-1-6 epitope (nephrin) in slit 
diaphragm area (Inoue et al., 2001).  
 
The interaction partners of FAT are not known but cadherins typically interact in a homophilic 
manner. The amino acid sequence of FAT contains conserved cadherin-like and EGF-like 
domains for calcium capture and areas for homophilic interaction indicating a possibility for 
calcium-dependent adhesion or/and a homophilic interaction (Dunne et al., 1995). In addition, the 
intracellular domain contains potential sequences for binding catenin and a PDZ-domain binding 
motif (Dunne et al., 1995; Ponassi et al., 1999).    
 
 
4.9. N-CAM 
 
In the podocytes neural cell adhesion molecule (N-CAM) has not been implicated in the nephrin-
associated protein complex. In the rat kidney, N-CAM has been observed in during development 
in the mesenchyme (Lackie et al., 1990) but it is not present in the adult kidney (Nouwen et al., 
1993). In the rat pancreas neural cell adhesion molecule (N-CAM) has been found in the 
endocrine cells and nerve endings (Rouiller et al., 1991; Cirulli et al., 1994).  Among the 
endocrine cells the expression of N-CAM has been reported to be either stronger in the non-β-
cells in the periphery of the islets and weaker in the β-cells (Cirulli et al., 1994) or equal 
(Langley et al., 1989; Esni et al., 1999). The proposed differential expression of N-CAM in the β- 
and non-β-cells has been suggested to participate in the islet cell segregation (Cirulli et al., 1994). 
The phenotype of N-CAM-deficient mice supports the hypothesis (Esni et al., 1999). In these 
mice, the α-cells are dispersed in the islets without the typical peripheral localisation (Esni et al., 
1999), and the clustering of cadherins, reorganisation of actin and formation of cell junctions are 
enhanced affecting the islet cell polarity (Cirulli et al., 1994). In addition, degranulation of β-
cells suggests a necessity of N-CAM for normal turnover of insulin secretory granuli (Esni et al., 
1999). These findings indicate that N-CAM negatively regulates the establishment of cadherin-
based adhesion.  
 
The β-cells have also been reported to express sialylated forms of N-CAM. Insulin secretion was 
found to positively correlate with the expression of polysialic acid N-CAM (PSA-N-CAM) 
(Bernard-Kargar et al., 2001).  
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AIMS OF THE PRESENT STUDY 
 
 
This study was designed to characterise nephrin expression and to search for potential nephrin 
interacting proteins in the kidney and pancreas. The specific aims of the present study were:  
 
-  to study the tissue distribution of nephrin expression (I),  
-  to characterise the expression of nephrin in the novel expression sites (I),   
- to characterise the kidney phenotype of nephrin-deficient TRAP mice generated by random 
insertional mutagenesis, an alternative to targeted mutagenesis (II), 
- to search for potential interaction partners of nephrin (III), 
- to examine whether the proteins proposed to form the nephrin-associated complex in the 
kidney are expressed in the pancreas, and whether they could have a potential to form the 
nephrin-associated protein complex of the pancreas (IV). 
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MATERIALS AND METHODS 
 
 
1. TISSUES (I-IV) 
 
The samples of human kidney cortices and pancreata were obtained from cadaveric donors 
unsuitable for transplantation (Division of Transplantation Surgery, University of Helsinki, 
Helsinki, Finland). Dr A. Miettinen (HUS Laboratory Diagnostics, the University Central 
Hospital, Helsinki, Finland), Dr O. Korsgren (University of Uppsala, Uppsala, Sweden) and Dr 
D. Eizirik (Free University of Brussels, Brussels, Belgium) provided samples of human pancreas, 
isolated pancreatic islets, and total pooled islet RNA, respectively.  
 
The nephrin TRAP mouse strain was created at National Research Center for Environment and 
Health Center for Environment and Health, Institute of Mammalian Genetics (Neuherberg, 
Germany) by electroporating mouse embryonic stem cells with the promoterless splice-acceptor 
type vector PT1βgeo (Hill, 1993; Townley et al., 1997; Wiles, 2000). Integration of the vector 
into the genome occured randomly with the help of splice donor/splice acceptor sites. Resistant 
clones were selected with 200 µg/ml neomycin and the site of integration was determined by 5’ 
RACE (rapid amplification of cDNA ends). Chimeric mice were generated by blastocyst 
injection of the trapped nephrin clone WO27B02. Male chimeras were bred on a C57BL/6 
genetic background. This nephrin TRAP mouse strain was transferred to the animal facilities of 
the Haartman Institute and Biomedicum (University of Helsinki, Helsinki, Finland). In this thesis 
the kidneys, pancreata and urine of nephrin TRAP mice were studied, and the tails were used for 
genotyping. Besides mouse tissues, normal rat kidneys and pancreata were also examined. The 
local research ethics committees accepted all experiments.  
 
 
2. CELLS (III) 
 
Mouse kidney epithelial collecting duct cell line M-1 (ATCC, Manassas, VA, USA) was used in 
this study. The cells were cultured in the equal mix of Ham’s F12 and Dulbeco’s modified 
Eagle’s medium (Sigma-Aldrich Corp., St-Louis, MO, USA) supplemented with 5 µM 
dexamethasone and 5% fetal bovine serum.  
 
 
3. METHODS  
 
3.1. RNA isolation (I, II, IV) 
 
Total RNA was isolated with Trizol (Life Technologies, Gibco BRL, Paisley, UK), a ready-to-
use solution of phenol and guanidine isothiocyanate. The method based on the single-step RNA 
isolation was described earlier (Chomczynski and Sacchi, 1987).  
 
Tissue samples were homogenised in the Trizol reagent and incubated for 5 min to disrupt cells 
and dissociate nucleoprotein complexes. After the addition of chloroform, the homogenate was 
centrifuged at 12 000 x g for 10 min to separate the sample into an aquenous, an interphase and a 
phenol phase. RNA was precipitated from the aquenous phase with an equal volume of 
isopropanol. After incubation of 10 min and repetition of the centrifugation step, the RNA pellet 
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was washed with 70% ethanol to remove salt. Finally, the air-dried RNA pellet was dissolved in 
RNase-free water.  
 
To eliminate residual DNA a sample of the isolated RNA was treated with 2 U of RQ1 RNase-
free DNase (Promega, Madison, WI, USA) in the presence of 40 U of RNasin® Ribonuclease 
Inhibitor (Promega) in the buffer (40 mM Tris-HCl, pH 8.0, 10 mM MgSO4, 1 mM CaCl2) for 30 
min at 37 ºC. The enzymes were removed by phenol/chloroform (1:2) extraction followed by 
chloroform/isoamylalcohol (1:25) treatment. Glycogen (Boehringer Mannheim, Mannheim, 
Germany), a 1/10 volume of 3 M ammonium acetate (pH 5.2) and 2.5 volumes of absolute 
ethanol were added to the aquenous phase. After centrifugation the precipitate was washed with 
70% ethanol, air-dried and dissolved in RNase-free water.  
 
 
3.2. Complementary DNA synthesis (I, II, IV)  
 
A sample of RNA was heated at 65 ºC for 5-10 min to unfold secondary structures. For 
complementary DNA (cDNA) synthesis poly-T primer (5 µM) (Boehringer Mannheim), 
deoxynucleotides (500 µM) (Finnzymes, Espoo, Finland), 12 U of RNasin® Ribonuclease 
Inhibitor (Promega) and 100 U of Moloney-Murine Leukemia Virus Reverse Transcriptase (M-
MLV RT) (Promega) were added in the buffer containing 50 mM Tris-HCl (pH 8.3), 75 mM 
KCl, 3 mM MgCl2, and 10 mM dithiothreitol. The cDNA synthesis was allowed to proceed for an 
hour at 37 ºC, and was stopped by heating for 5 min at 80 ºC.  
 
 
3.3. DNA isolation (II) 
 
Quantum Prep AquaPure Genomic DNA Isolation Kit (Bio-Rad, Hercules, CA, USA) was used 
for the isolation of genomic DNA from the tails of nephrin TRAP mice to allow the genotyping 
of the TRAP mice. Pieces of tail were incubated overnight at 55 ºC in Genomic DNA Lysis 
Solution supplemented with Proteinase K solution (100 µg/ml) to dissolve tissue particles. RNA 
was removed by RNAse treatment (20 µg/ml) for 60 min at 37 ºC. The remaining proteins were 
precipitated with Protein Precipitation Solution and centrifugation (15 000 x g) for 3 min. DNA 
was precipitated from the supernatant with isopropanol. The centrifugation step was repeated. 
The DNA pellet was washed with 70 % ethanol, centrifuged, air-dried, and dissolved in DNA 
Hydration Solution at 65 ºC.  
 
 
 3.4. Polymerase chain reaction (PCR) (I, II, IV) 
 
The polymerase chain reaction (PCR) was used for genotyping nephrin TRAP mice, production 
of probes, amplification of selected cDNA species for sequencing, and quantitation of the 
expression of nephrin mRNA. The primers used are summarised in Table 3. 
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No Target (Genbank number) Primer sequence (5’-3’) Used 
1 Human nephrin (AF035835) ccaacatcgttttcacttgg Probe production (I) 
2 Human nephrin (AF035835) gggaaggccatatcctcat Probe production (I) 
3 Human nephrin (AF035835) ccaacatcgttttcacttgg RT-PCR (I) 
4 Human nephrin (AF035835) gggtggtacgacatccacata RT-PCR (I) 
5 Human nephrin (AF035835) cccatcactaccccaggtct RT-PCR (I, IV) 
6 Human nephrin (AF035835) ctctgttgtgctgaccgtg RT-PCR (I, IV) 
7 Human nephrin (AF035835) atggccctggggacgac Sequencing (I) 
8 Human nephrin (AF035835) tggagaggatcactctgggagac Sequencing (I) 
9 Human nephrin (AF035835) agcgatgacgcggagtatg Sequencing (I) 
10 Human nephrin (AF035835) tctgggcgggatattttaacg Sequencing (I) 
11 Human nephrin (AF035835) gtcacatctccatgtccaacc Sequencing (I) 
12 Human nephrin (AF035835) aaggtgctcccagatttctcc Sequencing (I) 
13 Human nephrin (AF035835) aggctggtgtgtttggctat Sequencing (I) 
14 Human nephrin (AF035835) gattgctgctgacgctgac Sequencing (I) 
15 Human nephrin (AF035835) gtcagcgtcagcagcaatc Sequencing (I) 
16 Human nephrin (AF035835) ggaaggtccagttgaagg Sequencing (I) 
17 Human nephrin (AF035835) tggaccttccgcggctat Sequencing (I) 
18 Human nephrin (AF035835) tagttaggggagtggggtgctc Sequencing (I) 
19 Human nephrin (AF035835) ttcaccatgccaaactggc Sequencing (I) 
20 Human nephrin (AF035835) gggtggtacgacatccacat Sequencing (I) 
21 Human nephrin (AF035835) ccaacatcgttttcacttgg Sequencing (I) 
22 Human nephrin (AF035835) ctctgttgtgctgaccgtg Sequencing (I) 
23 Human nephrin (AF035835) cccatcactacccccggtct Sequencing (I) 
24 Human nephrin (AF035835) tccactggcctgaagacacatat Sequencing (I) 
25 Human nephrin (AF035835) aaagtgctgggattataggcgtg Sequencing (I) 
26 Human nephrin (AF035835) ccagagtagaaacaaggtgcatcc Sequencing (I) 
27 Human nephrin (AF035835) ttattttttgagacagaatctcgctct Sequencing (I) 
28 Rat nephrin (AF125521) tacgtagaattctcacaccagatgtcccctca Sequencing (I) 
29 Rat nephrin (AF125521) atctccaagaccccaggtacaca Taqman, RT-PCR (II) 
30 Rat nephrin (AF125521) ttggtgtggtcagagccaag Taqman, RT-PCR (II) 
31 Rat nephrin (AF125521) ccctcttcaaatgcacggccacca  Taqman (II) 
32 Mouse nephrin (AF172247) acctggagctaccctgcata TRAP genotyping, RT-PCR (II) 
33 LacZ in the PT1βgeo gaagaaggcacatggctga TRAP genotyping (II) 
34 LacZ in the PT1βgeo ccgcttgtcctctttgttagg  TRAP genotyping (II) 
35 Mouse nephrin (AF172247) ggacttggtaaggcagcaaa TRAP genotyping, RT-PCR (II) 
36 Mouse nephrin (AF191090) cggtacaggatctggctgtt RT-PCR (II) 
37 Mouse nephrin (AF191090) ctctctccacctcgtcataca RT-PCR (II) 
38 β-actin (BC016045) aaccgcgagaagatgacccagatcatgttt RT-PCR (I) 
39 β-actin (BC016045) agcagccgtggccatctcttgctcgaagtc RT-PCR (I) 
40 Rodent GAPDH  commercial (data not available) Taqman PCR (II) 
41 Rodent GAPDH commercial (data not available) Taqman PCR (II) 
42 Rodent GAPDH commercial (data not available) Taqman PCR (II) 
43 CD2AP (AF164377) ccaaagatgcctggaagaag RT-PCR (IV) 
44 CD2AP (AF164377) agaagcactggaaggtgttga RT-PCR (IV) 
45 Podocin (AJ279254) cgcacaaggagaacaagagg RT-PCR (IV) 
46 Podocin (AJ279254) gagtttggagacgaaggtcaa RT-PCR (IV) 
47 Podocin (AJ279254) caaagtgcggatgattgct RT-PCR (IV) 
48 Podocin (AJ279254) aggatttagtggctcaacagg RT-PCR (IV) 
49 Podocin (AJ279254) atcgcccaagatgcaaag RT-PCR (IV) 
50 Podocin (AJ279254) tgaagggtgtggaggtatcg RT-PCR (IV) 
51 NEPH1 (AY017369) ccagaggacaccaggattga RT-PCR (IV) 
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52 NEPH1 (AY017369) ttcggcaagtgaagacacg RT-PCR (IV) 
53 NEPH2 (AF480410) catcatctccagcacccaga RT-PCR (IV) 
54 NEPH2 (AF480410) tgccataaggacgaggaagg RT-PCR (IV) 
55 NEPH2 (AF480410) ccggagtggtcctgagcaat RT-PCR (IV) 
56 NEPH2 (AF480410) cttgatctggcccttctcgc RT-PCR (IV) 
57 NEPH3 (XM_048304) tgaccatctgcattgagagg RT-PCR (IV) 
58 NEPH3 (XM_048304) tccttgggtccaagtctttc RT-PCR (IV) 
59 Densin (AF434715) gtcccagcaaagcaacatt RT-PCR (IV) 
60 Densin (AF434715) tccaccactgatactaaatccaag RT-PCR (IV) 
61 FAT (NM_005245) cctctgaacctcacccacat RT-PCR (IV) 
62 FAT (NM_005245) ccacagacaccttttcatcg RT-PCR (IV) 
63 synaptopodin (Y11072) attgacatccagcccaacac RT-PCR (IV) 
64 synaptopodin (Y11072) catcatcctcctttccacca RT-PCR (IV) 
65 KIAA1029 (NM_007286) tgccaaggtctcaccaaga RT-PCR (IV) 
66 KIAA1029 (NM_007286) ggctgctcatgctgctc RT-PCR (IV) 
 
Table 3. Summary of the primers. The summary shows the accession numbers of the targets, the primer 
sequences, the applications, and the original articles in which the respective primers have been used. 
Abbreviation: GAPDH, glyceraldehyde-3-phosphate dehydrogenase (Applied Biosystems, Foster City, 
CA, USA).  
 
 
3.4.1. Taqman Real Time PCR (II) 
 
Taqman Real-Time PCR is based on the 5’-nuclease assay (Holland et al., 1991). It was used to 
quantitate the expression of nephrin mRNA. The analysis was performed with a Taqman 
Universal Master Mix reagent in Real-Time PCR ABI Prism 7700 Sequence Detector System 
(Applied Biosystems) with the protocol: 2 min at 50 °C, 10 min at 94 °C, followed by 40 
amplification cycles (94 °C 15 sec, 60 °C 1 min). The primer 29 (900 nM), the primer 30 (300 
nM) and the 6-carboxy-fluorescein (FAM) labelled probe (the primer 31) (225 nM) were used for 
the amplification of nephrin cDNA (Table 3). The GAPDH primers (150 nM) and the VIC™ 
labelled probe (the primers 40-42) (100 nM) (Applied Biosystems) were used for the 
amplification of GAPDH cDNA. The expression level of GAPDH, a housekeeping gene was 
used to normalise the expression results of nephrin. The difference between nephrin expression in 
nephrinwt/wt and nephrinwt/trap mice was examined by two-tailed Mann-Whitney test using the 
Prism analysis program (Graphpad, San Diego, CA, USA) for statistical significance – a p value 
less than 0.05.  
 
3.4.2. Conventional PCR (I, II, IV) 
 
The basic conventional PCR was performed using AmpliTaq (Perkin Elmer, Norwalk, CT, USA) 
or Ext (Finnzymes) DNA polymerase with initial denaturation of cDNA at 94 °C for 3 min, 
followed by 18-40 amplification cycles (94 °C 30 sec, 56 °C 45 sec, 72 °C 45 sec), and the final 
elongation at 72 °C for 5 min. The PCR reaction mixture contained 0.5 U of DNA polymerase, 
200 µM of deoxynucleotides, and 400 nM of each primer in 10 mM Tris-HCl (pH 8.3), 50 mM 
KCl, 1.5 mM MgCl2. The exact PCR conditions are dependent on several factors, such as a target 
sequence, primers, and a length of an amplicon. Thus, the basic PCR protocol was modified, if 
necessary.  
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The PCR reactions were analysed by agarose gel electrophoresis, and when necessary, the PCR 
products were gel-purified for sequencing with the QIAquick PCR Purification Kit (Qiagen, 
Hilde, Germany), a method based on the pH and salt concentration dependent binding properties 
of silica-membrane in the spin-column (Vogelstein and Gillespie, 1979).  
 
 
3.5. Sequencing (I, II, IV) 
 
The coding sequence of nephrin mRNA was amplified and sequenced from human pancreatic 
cDNA (I). Sequencing was also utilised to locate the TRAP vector (II) and to verify the presence 
of selected mRNA species of the glomerular nephrin-associated molecular complex in the 
pancreas (IV). The primers used for the amplification and subsequent sequencing of the gel-
purified PCR products are summarised in Table 3. Sequencing was performed with an Amersham 
Thermo SequanaseTM II dye terminator cycle sequencing premix kit (Amersham Pharmacia 
Biotech, Uppsala, Sweden) and with the ABI Prism® 373A sequencer (Applied Biosystems).  
 
 
3.6. Human tissue mRNA dot blot analysis (I) 
 
Human RNA Masterblot (Clontech Laboratories, Palo Alto, CA, USA) with mRNA species from 
50 different adult or fetal tissues was used to study the tissue distribution of nephrin mRNA. The 
dot blot was hybridised with the nephrin probe including nucleotides 2606-3382 (GenBank 
AF035835). The probe was constructed by PCR with the primer 1 and 2 (Table 3) and labelled 
with 
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phosphorus-deoxycytidinetriphosphate by random priming (Boehringer Mannheim). The 
hybridisation was performed in a buffer containing 5xSSC (750 mM sodium chloride, 75 mM 
sodium citrate, pH 7.0), 5xDenhard’s, 50 mM sodium phosphate, 50 % formamide, 0.1 % sodium 
dodecyl sulphate (SDS), and 250 µg/ml denatured Herring sperm overnight at 42 ºC. The dot blot 
was washed with 2xSSC, 0.1 % SDS at 42 °C and 1xSSC, 0.1 % SDS at 55 °C, and analysed 
after 3 days’ exposure with a Bio-imaging analyser (Fuji Photo Film Co, Kanakawa, Japan).    
 
 
3.7. Coimmunoprecipitation (III) 
 
M-1 cells expressing endogenously nephrin and CD2AP were lysed in 20 mM HEPES (pH 7.6), 
150 mM NaCl, 1 mM CaCl2, 1 % NP-40, 0.5 % saponin, supplemented with an EDTA-free 
proteinase inhibitor cocktail (Roche, Basel, Switzerland). Equal volumes of the cell lysate were 
incubated with rabbit anti-nephrin (Holthofer et al., 1999), rabbit anti-CD2AP (Lehtonen et al., 
2000) or rabbit preimmune serum with rotation for 1 hour at 4 ºC followed by incubation with 
protein A-sepharose beads (Zymed Laboratories Inc., South San Fransisco, CA). The 
immunocomplexes were collected by centrifugation at 2400 x g for 60 sec, and washed three 
times with the lysis buffer. Finally, the samples were prepared for SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and subsequent immunoblotting by suspending them in Laemmli’s 
sample buffer (LSB) (Bio-Rad) followed by heating at 95 ºC for 5 min. The presence of CD2AP 
in the sample precipitated with rabbit anti-nephrin was monitored by immunoblotting with rabbit 
anti-CD2AP (Lehtonen et al., 2000). The presence of nephrin in the sample precipitated with 
rabbit anti-CD2AP was monitored by immunoblotting with rabbit anti-nephrin (Holthofer et al., 
1999). Immunoblotting was performed as described in 3.9. 
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3.8. Pulldown assay (III) 
 
The glutathione S-transferase (GST) fusion proteins of the first SH3 domain (amino acids 1-59), 
the second SH3 domain (amino acids 108-169), the third SH3 domain (amino acids 269-330) or 
the carboxy terminus (amino acids 331-637) of CD2AP (GenBank AF149092) were tested for 
their ability to pulldown endogenous nephrin in the M-1 cell lysate prepared as above. The GST 
fusions of CD2AP, or GST alone (a negative control) were added to the lysates and incubated 
with rotation for 1 hour at 4 °C. The glutathione Sepharose bound proteins were collected by 
centrifugation at 1000 x g for 3 min at 4 °C, washed three times with the lysis buffer, suspended 
in LSB, boiled i.e. prepared for SDS-PAGE, and immunoblotting with rabbit anti-nephrin 
(Holthofer et al., 1999) to reveal which fragment(s) of CD2AP are able to pull nephrin down.  
 
 
3.9. Immunoblotting (I-IV) 
 
Immunoblotting was used to show nephrin and the proteins of the proposed glomerular nephrin-
associated assembly in pancreatic lysates (I, IV), to study nephrin in nephrin TRAP mice (II, 
unpublished), and to demonstrate an interaction between nephrin and CD2AP (III). The samples 
for immunoblotting were homogenised in the RIPA buffer (150 mM NaCl, 1 % NP-40, 0.5 % 
deoxycholic acid, 0.1 % SDS, 50 mM Tris-HCl (pH 8), 0.02 % NaN3) (II, IV) or urea buffer (8 M 
urea, 1 mM dithiothreitol, 1 mM ethylene diamine tetraacetic acid disodiumsalt-2 hydrate) (IV). 
An equal volume of 4xLSB (125 mM Tris-HCl (pH 6.8), 17.4 % glycerol, 4 % SDS, 10 % 2-
mercaptoethanol, 0.1 % bromophenolblue) was added. Alternatively, the samples were lysed 
directly in 2xLSB (I), LSB (BioRad) (III) or 3xLSD (IV, unpublished). After homogenisation, the 
lysates were boiled for 5-10 min, and centrifuged. Proteins of the supernatants were resolved with 
SDS-PAGE and transferred onto nitrocellulose filters (Amersham Biosciences, Uppsala, Sweden 
or Schleicher&Schuell, Dassel, Germany). 
 
The filters were blocked at least for two hours in 3 % bovine serum albumin or 5 % skimmed 
milk in phosphate buffered saline (PBS) (140 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, 8.2 mM 
Na2HPO4, pH 7.4), incubated at least for 2 hours with a primary antibody (Table 4), washed with 
PBS containing 0.1 % Tween 20 or 0.2% Triton X-100. After the wash the membranes were 
incubated with appropriate horseradish peroxidase conjugated secondary antibodies (Dako, 
Glostrup, Denmark or Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA). 
After the wash, the bound antibodies were detected with Enhanced ChemiLuminescent substrate 
(Amersham Biosciences or Pierce, Rockford, IL, USA). 
    
Primary antibody (source/reference) Used  
Rabbit anti-nephrin (Ahola et al., 1999; Holthofer et al., 1999)  I, II, III 
Rabbit anti-CD2AP (Lehtonen et al., 2000)  III 
Rabbit anti-CD2AP (sc-9137 Santa Cruz, Biotechnology Inc., Santa Cruz, CA, USA)  IV 
Rabbit anti-podocin (Roselli et al., 2002b)  IV 
Rabbit anti-FAT (Inoue et al., 2001)  IV 
Rabbit anti-densin (Izawa et al., 2002) IV 
Rabbit anri-NEPH1 (Sellin et al., 2002)  IV 
Rabbit anti-filtrin (Ihalmo et al., 2002)  IV 
Mouse anti-synaptopodin (65194 Progen, Heidelberg, Germany)  IV 
Mouse anti-α-actinin-4 (Honda et al., 1998)  IV 
 
Table 4. Summary of the antibodies used in the immunoblots.  
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3.10. Immunofluorescence (I, III, IV) 
 
Immunofluorescence was used for the colocalisation of nephrin with insulin, glucagon, 
somatostatin and cytokeratin 18 in the pancreas (I), for the colocalisation of nephrin and the 
proposed nephrin-associated proteins in M-1 cells (III) as well as for the colocalisation of insulin 
with the proteins of the proposed glomerular nephrin-associated complex in the pancreas (IV). 
Cryostat sections of kidney cortex and pancreas or M-1 monolayer cells on coverslips were fixed 
in ice-cold acetone, 3.5 % paraformaldehyde (PFA), or in both, followed by washes with PBS. 
For permeabilisation, the PFA fixed samples were pretreated with 0.1 % Triton X-100 in PBS for 
15 min, washed with PBS, and blocked with 10 % normal goat serum for 30 min. The samples 
were further incubated with primary antibodies (Table 5) for 1 hour.  
 
Primary antibodies (source/reference) Used 
Rabbit anti-nephrin (I) I 
Rabbit anti-nephrin (Ahola et al., 1999; Holthofer et al., 1999) II, III 
Rabbit anti-nephrin (unpublished) IV 
Mouse anti-nephrin (III) III 
Mouse anti-insulin (MS-456-P1 Neomarkers, Fremont, CA, USA) I, IV 
Guinea pig anti-insulin (18-0067 Zymed) IV 
Sheep anti-glucagon (4660-0930 Biogenesis, Poole, UK) I 
Mouse anti-somatostatin (8330-0496 Biogenesis) I 
Mouse anti-cytokeratin 19 (M0888 Dako) I 
Rabbit anti-CD2AP (1774) (Lehtonen et al., 2000) II, III 
Rabbit anti-CD2AP (R211) (Lehtonen et al., 2002) III 
Rabbit anti-CD2AP (sc-9137 Santa Cruz) III, IV 
Rabbit anti-podocin (Roselli et al., 2002b) III, IV 
Rabbit anti-podocalyxin (Miettinen et al., 1999) II 
Rat anti-TROMA 1 (Kemler et al., 1981) II 
Rabbit anti-α−actinin-4 (Honda et al., 1998) III 
Mouse anti-α−actinin-4 (Honda et al., 1998) IV 
Rabbit anti-FAT (Inoue et al., 2001) IV 
Rabbit anti-densin (Izawa et al., 2002) IV 
Rabbit anri-NEPH1 (Sellin et al., 2002)  IV 
Rabbit anti-filtrin (Ihalmo et al., 2002)  IV 
Mouse anti-synaptopodin (65194 Progen, Heidelberg, Germany)  IV 
Rabbit anti-ZO-1 (61-7300 Zymed) II, IV 
Mouse anti-E-cadherin (C20820 BD Biosciences, Franklin Lakes, NJ, USA)  IV 
 
Table 5. Summary of the antibodies used in immunofluorescence, immunoelectron microscopy, and 
immunohistochemistry.  
 
 
After incubation with the primary antibodies, the sections and cells on coverslips were washed 
and incubated with appropriate fluorescent secondary antibodies purchased from Jackson 
ImmunoResearch - except rabbit anti-guinea pig purchased from Zymed. After a PBS wash, the 
samples were embedded in Immu-Mount embedding medium (Shandon, Pittsburgh, PA). 
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Microscopy was performed with a Zeiss Axiophot2 microscope (Carl Zeiss Jena GmbH, Jena, 
Germany).  
 
 
3.11. Whole-mount immunofluorescence (II) 
 
Whole-mount immunofluorescence was performed to examine ureter branching in nephrin TRAP 
mice. For this purpose the kidneys of nephrinwt/wt (n=2), nephrinwt/trap (n=6) and nephrintrap/trap 
mice (n=4) were dissected on E12 and transferred on filters (Nuclepore Corp., Pleasanton, CA, 
USA) with the average pore size of 1 µm. The tissues were cultivated in Modified Eagle’s 
Medium supplemented with 10 % fetal calf serum, 2 mM glutamine and antibiotics at 37° C for 6 
days. The kidneys were fixed for 5 min in ice-cold methanol, washed with PBS and incubated in 
rat anti-TROMA 1 recognising cytokeratin 8 (Table 5) at 4 °C overnight. After a PBS wash, the 
samples were treated with fluorescein isothiocyanate conjugated secondary antibody at 4 °C 
overnight. After washing with PBS the kidneys were mounted with 50 % glycerol in PBS 
supplemented with 100 mg/ml 1,4-diazabicyclo-(2.2.2)-octane (Sigma, St. Louis, MO, USA). 
Fluorescence microscopy was performed with Olympus microscope (Olympus Optical Co., Ltd., 
Tokyo, Japan). The extent of ureter branching was quantified by counting the dichotomal 
divisions. 
 
 
3.12. Histochemistry and immunohistochemistry (II) 
 
Histochemistry was used to evaluate the morphology of kidneys in nephrin TRAP mice, and 
immunohistochemistry to investigate the immunoreactivity pattern of nephrin (Ahola et al., 1999; 
Holthofer et al., 1999), ZO-1 (Zymed), and podocalyxin (Miettinen et al., 1999) (Table 5). For 
histochemistry the dissected kidneys from newborn mice were fixed in 3.5 % PFA, embedded in 
paraffin, sectioned, deparaffinised, and hematoxylin counterstained. For immunohistochemistry 
the deparaffinised sections were the antigen unmasked with a microwave treatment and stained 
with HISTOMOUSE-SP kit (Zymed). The sections were analysed with an Olympus BX50 
microscope (Olympus).  
 
 
3.13. Electron microscopy and immunoelectron microscopy (II, III) 
 
Electron microscopy was used for studying the subcellular morphology of the kidneys of nephrin 
TRAP mice (II) and subcellular localisations of CD2AP and nephrin in the kidneys (III). The 
indirect immunoelectron microscopy was performed essentially as described earlier (Breiteneder-
Geleff et al., 1997). Briefly, for electron microscopy mouse kidneys from one-week-old mice 
were fixed with 3.5 % PFA, 0.05 % glutaraldehyde in PBS at 4 °C or for immunoelectron 
microscopy cortical kidney biopsies were fixed in freshly prepared 4 % PFA in PBS at 4 °C. The 
ultrathin sections of the biopsies were incubated with primary antibodies, rabbit anti-nephrin 
(Ahola et al., 1999; Holthofer et al., 1999) or rabbit anti-CD2AP (R211) (Lehtonen et al., 2002) 
(Table 5), followed by incubation with 10-nm gold-conjugated goat anti-rabbit immunoglobulins 
(Amersham Biosciences). The sections were counterstained with lead citrate. 
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3.14. Determination of urinary protein level (II) 
 
Urinary protein levels of nephrin TRAP mice from a litter including nephrintrap/trap (n=1), 
nephrinwt/trap (n=1) and nephrinwt/wt (n=2) mice were determined with an Uristix (Bayer, 
Bridgend, UK) protein assay. The results of this semiquantitative test were analysed visually.  
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RESULTS 
 
 
1.  Expression of nephrin in human pancreas (I, IV) 
 
The RNA dot blot including mRNA species from 50 different adult and fetal human tissues was 
used to study the expression of nephrin mRNA. The hybridisation signal with the nephrin probe 
was detected in fetal and mature kidney as well as in the pancreas. Other tissues studied showed 
no positivity.  
 
The expression of nephrin mRNA in human pancreas was verified by PCR. The overlapping PCR 
products covering the whole open reading frame region of nephrin mRNA were sequenced, and 
the sequence was found to be similar to that of nephrin in the kidney glomeruli. Both mRNA 
isoforms of human nephrin, the exon 24 containing nephrin and the α-nephrin lacking exon 24 
encoding the transmembrane region, were also detected in the pancreas.  
 
Immunoblotting and immunofluorescence were used to characterise which pancreatic cells 
express nephrin. A 165-kDa band was observed in human pancreas lysate and in the lysate made 
of the islets of Langerhans. When analysing equal amounts of the pancreas and islet lysates, the 
protein band was found to be enriched in the islet lysate. The preincubation of rabbit anti-nephrin 
with the antigenic peptide was found to abolish the immunoreactivity confirming the specificity 
of the antibody.  
 
By immunofluorescence nephrin was located to the islets of Langerhans with rabbit anti-nephrin 
raised against the aminoterminal part of nephrin (amino acids 1-324) (I). No immunoreactivity 
was detected after preadsorbing rabbit anti-nephrin with the antigen prior to the staining. Rabbit 
anti-nephrin made against the intracellular part of nephrin also showed immunoreactivity in the 
islets of Langerhans (IV). Further double immunofluorescence revealed colocalisation of nephrin 
with insulin (I, IV) while no colocalisation was observed with glucagon, somatostatin or 
cytokeratin 19 positive cells (I).   
 
 
2. Characterisation of nephrin-deficient TRAP mice (II) 
 
Gene trapping is an alternative method to targeted gene mutagenesis to disrupt gene functions. It 
is based on random insertional mutagenesis (Townley et al., 1997; Cecconi and Meyer, 2000). In 
the gene trapping technique, mouse embryonic stem cells are electroporated with a promoterless 
splice-acceptor type TRAP vector containing e.g. selector and marker genes, a poly-A tail and a 
translation stop codon. The resistant clones are isolated, and the site of integration is determined 
by 5’ RACE.  
 
In the nephrin TRAP mice, the trap vector was found in an inverted orientation in the 5’ end of 
exon 8. The integration site of the vector was verified by sequencing from both ends the 2.5 kb 
PCR fragment produced with the primers 32 (in exon 7) and 33 (in LacZ in the PT1βgeo vector). 
A translation stop codon was found after 14 amino acid encoding triplets in the reversed vector 
sequence.  Due to the inverted orientation, however, the poly-A tail in the vector was changed to 
the poly-T tail. 
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For genotyping of TRAP mice, the primer 32 (in exon 7) and 35 (in exon 9) amplifying a 524 bp 
product, were used for the detection of the wild type nephrin sequence. The mutant allele was 
recognised with the primer 34 (in the trap vector) and 35 (in exon 9) resulting in a 471 bp 
product. Among all genotyped mice (n=147) there were 45 nephrinwt/wt, 88 nephrinwt/trap and 14 
nephrintrap/trap mice. The nephrintrap/trap mice died soon after birth with one exception that survived 
for 7 days. At least 9 pups were lost before genotyping due to maternal cannibalism. The 
genotyping of the E12 and E18 embryos (n=28) showed 6 nephrinwt/wt, 11 nephrinwt/trap and 11 
nephrintrap/trap mice.  
 
RT-PCR was used to examine the expression of nephrin mRNA in the nephrinwt/wt, nephrinwt/trap 
and nephrintrap/trap kidneys and pancreata. No nephrin mRNA expression was observed in the 
nephrintrap/trap kidneys (II). Figure 7 shows the absence of the nephrin band in the cDNA of the 
nephrintrap/trap pancreata while the cDNA of the nephrinwt/wt and nephrinwt/trap shows the nephrin 
band by PCR (unpublished). However, it seems that these results only reflect the decreased 
amounts of nephrin cDNA in nephrintrap/trap mice as with increased PCR cycles the nephrin band 
was observed in the nephrintrap/trap kidneys as well as in the pancreas. Apparently, due to the 
inverted orientation of the vector in DNA, the nephrin mRNA synthesis was not completely 
inhibited. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. RT-PCR and immunoblot analysis of the nephrin TRAP pancreata. Pancreatic cDNA of 
nephrin TRAP mice was amplified by PCR with the nephrin primers 32 and 35 and with the β-actin 
primers 38-39 (Table 3). The nephrin PCR showed the absence of the nephrin band (upper band) in (1) 
the nephrintrap/trap pancreas (-/-), and the presence of the nephrin band in (3) the nephrinwt/trap (+/-) and (5) 
nephrinwt/wt pancreas (+/+). The lower band represents primer dimers. The respective samples without the 
reverse transcriptase reaction (2, 4, 6) and the “no template” control (7) showed no amplification of the 
nephrin cDNA confirming the RNA-origin of the signals. The β-actin PCR exhibited a band of an 
approximately equal intensity in all genotypes (1, 3, 5). The respective samples without the reverse 
transcriptase reaction (2, 4, 6) and the “no template” control (7) were negative. Immunoblotting, IB, 
showed the nephrin band in (1) the nephrinwt/wt pancreata. The protein was practically absent in (2) the 
nephrinwt/trap and (3) nephrintrap/trap pancreata.  
 
 
The comparison of the nephrinwt/wt and nephrinwt/trap kidneys by the quantitative real time PCR 
method showed a 63% reduction of the nephrin-specific transcript in the kidneys of the 
nephrinwt/trap mice. The nephrin levels in the pancreas have not been quantitated yet by real time 
PCR.  
 
Immunoblotting was used to investigate the presence of nephrin in nephrin TRAP mice. Rabbit 
anti-nephrin recognised a protein band doublet approximately at 180 kDa in the nephrinwt/wt and 
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nephrinwt/trap kidneys but not in the nephrintrap/trap kidneys (II). In the pancreata, the nephrin band 
was found in the nephrinwt/wt lysate (Figure 7) (unpublished). In the nephrinwt/trap and 
nephrintrap/trap lysates only a trace of immunoreactive nephrin could be seen after careful 
examination suggesting a minor leakage of the TRAP vector inserted in the splicing site (Figure 
7).       
 
The branching of the ureter tree during embryogenesis of nephrin TRAP mice was studied by 
counting of the dichotomal divisions (II). On an average, the number of the dichotomal divisions 
did not differ between the genotypes (5.5 in nephrinwt/wt, 6.2 in nephrinwt/trap and 5.0 in 
nephrintrap/trap mice). However, an extra single branch extending from the main trunk of the ureter 
tree was found in half of the nephrintrap/trap kidneys. These findings suggest that the branching of 
the ureter tree is not seriously affected by nephrin deficiency. 
 
In histology, the nephrintrap/trap kidneys were generally unorganised. The glomeruli appeared 
fibrotic, hypercellular and contained accumulations of extracellular material. The Bowman’s 
capsules and tubules showed dilatations and cysts. Electron microscopy revealed a distorted 
ultrastructure of the nephrintrap/trap glomeruli. Over 90 % of the foot processes of the podocytes 
were flattened and fused. The slit diaphragms were missing and replaced with narrow contact 
areas between adjacent podocytes. In the nephrinwt/trap glomeruli ~30 % of the foot processes 
appeared flattened but the slit diaphragms were present. No detachment of the podocytes from 
GBM was detected in the nephrintrap/trap or nephrinwt/trap glomeruli.   
 
The effect of loss of nephrin on other selected proteins of the podocytes was examined by 
immunohistochemistry. The nephrintrap/trap kidneys were immunostained with antibodies against 
CD2AP (a basolateral marker), podocalyxin (an apical marker) and ZO-1 (a tight junction 
marker). No major differences were detected in the intensities of the immunoreactivities between 
nephrinwt/wt, nephrinwt/trap and nephrintrap/trap mice. The immunoreactivity for podocalyxin, 
however, was found more punctate in the nephrintrap/trap kidneys when compared to that in 
nephrinwt/wt and nephrinwt/trap kidneys.  
 
The first results of the E17 nephrintrap/trap or nephrinwt/trap pancreata suggest no apparent 
abnormalities. By immunohistochemistry the presence of insulin, glucagon, somatostatin, 
amylase and cytokeratin 18 positive cells was observed (unpublished). 
 
Nephrintrap/trap mice appeared heavily proteinuric (>20 mg/ml) while nephrinwt/trap and nephrinwt/wt 
mice exhibited no proteinuria or showed only a trace of protein.  
 
 
3. Identification of putative nephrin-associated proteins (III, IV) 
 
In order to search for proteins in the vicinity of nephrin, double immunofluorescence was 
utilised. Immunoelectron microscopy was used for the verification of the immunofluorescence 
results, and finally the suggested interactions were tested by coimmunoprecipitations and 
pulldowns.  
 
Frozen sections of human kidney cortex were immunostained with mouse anti-nephrin together 
with rabbit anti-CD2AP, -podocin or -α-actinin-4 (III). Nephrin showed an epithelial linear 
patchy immunoreactivity along the capillary loops, resembling that of CD2AP. In the double 
immunofluorescence experiments the CD2AP signal was weaker probably due to different 
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optimal fixation conditions of nephrin and CD2AP. In the merged image, nephrin and CD2AP 
partially colocalised. Podocin and nephrin also showed a partial colocalisation. In contrast, 
nephrin and α-actinin-4 did not typically colocalise although they were found in close spatial 
locations.  
 
Nephrin and CD2AP were selected for further examination with immunoelectron microscopy. 
Both proteins were found in the slit diaphragm area further proposing the possibility for their 
interaction (III).  
 
 
3.1. Interaction between nephrin and CD2AP (III) 
 
In the glomeruli, nephrin and CD2AP were found to be rather insoluble in conditions retaining 
protein-protein interactions. Thus, the M-1 epithelial collecting duct cells were chosen for the 
interaction experiments as they were found to express endogenously both nephrin and CD2AP as 
judged by immunofluorescence and immunoblotting. Nephrin showed a rather weak but clear 
immunoreactivity along the plasma membranes in these cells. The CD2AP immunoreactivity was 
found in the cytoplasm and in the close vicinity of the cell membranes. In addition, both nephrin 
and CD2AP showed occasional concentrations near the plasma membranes. M-1 cells were also 
found to express podocin and α-actinin-4. The weak podocin immunoreactivity resembled that of 
nephrin. In contrast, α-actinin-4 gave a cytoplasmic filamentous pattern different from that of 
nephrin.  
 
The interaction of endogenously expressed nephrin and CD2AP was examined with reciprocal 
coimmunoprecipitation in wild-type M-1 cells. The M-1 lysate precipitated with rabbit anti-
nephrin and immunoblotted with rabbit anti-nephrin (Holthofer et al., 1999) showed a 180-kDa 
band of nephrin, and when immunoblotted with rabbit anti-CD2AP (Lehtonen et al., 2000) 
revealed the 80-kDa band of the coprecipitated CD2AP. Conversely, the M-1 lysate precipitated 
with rabbit anti-CD2AP and immunoblotted with rabbit anti-nephrin showed the band of the 
coprecipitated nephrin, and when immunoblotted with rabbit anti-CD2AP, revealed the presence 
of CD2AP. The M-1 lysate precipitated with preimmune sera showed no bands verifying the 
specificity of the coimmunoprecipitations. 
 
To find out which domain(s) of CD2AP are necessary for the interaction with nephrin, the three 
SH3 domains of CD2AP, the carboxy terminus of CD2AP and GST as a negative control were 
challenged for their ability to pull down the endogenous nephrin of M-1 cells. Each pulldown 
trial was resolved with SDS-PAGE, and immunoblotted with rabbit anti-nephrin. The first and 
third SH3 domains were able to pull down nephrin (Figure 8). In high stringency conditions only 
the third SH3 domain of CD2AP was found to mediate of the interaction with nephrin (III).  
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Figure 8. Nephrin pulldown by the individual SH3 domains of CD2AP. The immunoblot is stained 
with rabbit anti-nephrin. Human glomeruli were used as a positive control (lane 1). M-1 lysate shows two 
bands of nephrin (lane 2). The upper band equals the size of nephrin in human glomeruli (~185 kDa) and 
the ~160-kDa band represents apparently a differentially modified nephrin. The GST fusions of the first 
(lane 3), second (lane 4), third SH3 domain (lane 5) of CD2AP and GST (lane 6) were used in the 
pulldown. The first and third SH3 domains were able to pull nephrin down. 
 
 
3.2. Pancreatic expression of the proposed glomerular nephrin-associated molecules (IV) 
 
RT-PCR, sequencing, immunoblotting, and immunofluorescence were utilised to examine the 
pancreatic expression of the proposed glomerular nephrin-associated molecules and to localise 
them in the pancreas to identify those ones near pancreatic nephrin for further evaluation with 
immunoelectron microscopy and with coprecipitation studies.  
 
Human pancreatic cDNA was amplified with the nephrin primers 3-4, the CD2AP primers 43-44, 
the podocin primers 45-46, 47-48 and 49-50, the NEPH1 primers 51-52, the NEPH2 primers 53-
54 and 55-56, the filtrin primers 57-58, the densin primers 59-60, the FAT primers 61-62, the 
synaptopodin primers 63-64, and the synaptopodin (KIAA1029) primers 65-66 (Table 3). 
Besides nephrin, the amplification of cDNA of CD2AP, FAT, densin, NEPH1, NEPH3 (filtrin), 
and synaptopodin was found (Table 6). The amplified products with the expected size were found 
to be correct by sequencing. PCR with both NEPH2 primer pairs showed no amplification of 
NEPH2 cDNA, and podocin cDNA was amplified only with the primer pair covering the 
nucleotides 790-1052 partly encoding the band-7 stomatin family motif. The sequence of the 
amplified product, however, corresponded to podocin cDNA. The other pairs of podocin tested 
revealed no amplification.  
 
Immunoblotting was performed to study whether the detected mRNA species are translated into 
proteins in the pancreas (Table 6). The immunoblotting analysis of these proteins has been 
performed earlier with kidney lysates. Thus, the pancreatic lysates were analysed together with a 
lysate of kidney-origin to allow comparison. CD2AP- (~80 kDa), NEPH1- (~67 kDa), filtrin- 
(~100 kDa), FAT- (>500 kDa), and α-actinin-4- (~100 kDa) specific bands were detected in the 
pancreas. This correlated with results obtained from the kidney. The size of pancreatic densin 
appeared to correspond to the size to densin in the CNS (Apperson et al., 1996).  
 
Rabbit anti-podocin recognised a protein with an unexpected size. The deduced molecular mass 
of podocin is ~42 kDa (Boute et al., 2000a), and the protein has been reported to migrate at ~49 
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kDa (Roselli et al., 2002b). The polyclonal podocin antibody showed a band of the expected size 
~44 kDa in the glomeruli but the band detected in the pancreas lysate was smaller (~35 kDa). The 
NCBI database and blast comparisons revealed an alternatively spliced form of podocin lacking 
exon 5 predicting a protein of ~35 kDa (Altschul et al., 1990; Benson et al., 2000) equaling the 
size of the protein band in the pancreas lysate. This finding would explain the immunoblot result 
but does not explain the difficulty to detect the mRNA sequence of podocin with diverse podocin 
primers outside exon 5. One explanation could be an existence of another podocin-like sequence 
that could explain the exact short podocin sequence partially overlapping the sequence of the 
stomatin family motif. The podocin antibody has been made against the carboxy terminus of 
podocin containing the band-7-stomatin family motif (Boute et al., 2000a; Roselli et al., 2002b), 
and thus, it may potentially also recognise another member of the stomatin family. It appears 
likely that the typical podocin is not expressed in the pancreas supporting the previous findings 
showing a very narrow pattern of expression of podocin, restricted practically to the glomerular 
podocytes (Boute et al., 2000a) and a podocyte-specificity of the podocin promoter (Moeller et 
al., 2002).  
 
Besides the expected bands in immunoblots both lysates showed some extra bands that may 
result from alternative splicing or differential posttranslational modifications. Alternative splicing 
has been reported for podocin (IV), filtrin (Ihalmo et al., 2002), FAT (Dunne et al., 1995), and 
densin (Wang et al., 2003). In addition, for instance NEPH1 (Donoviel et al., 2001; Sellin et al., 
2002), filtrin (Ihalmo et al., 2002), densin (Apperson et al., 1996), and FAT (Dunne et al., 1995) 
have potential glycosylation sites. 
 
The localisation of CD2AP, NEPH1, filtrin, FAT, densin, and α-actinin-4 as well as the atypical 
podocin found in the pancreas was studied by immunofluorescence to determine which proteins 
are in the vicinity of nephrin in the pancreas (Table 6). Nephrin has been shown to colocalise 
with insulin in the β cells (I, IV). As most antibodies used in this study were polyclonal, like the 
nephrin antibody, the selected proteins were tested for their colocalisation with insulin, which 
was detected by a monoclonal antibody. Alpha-actinin-4 was tested for its colocalisation with 
nephrin. 
 
FAT, densin, and α-actinin-4 were localised in the islets of Langerhans but not limited to the 
endocrine tissue (IV). FAT was found to colocalise with insulin, and α-actinin-4 (detected by a 
monoclonal antibody) with nephrin. Densin was localised in the islets of Langerhans. The 
immunoreactivity pattern showed the presence of densin in the β-cells. 
 
As judged by the immunoreactivity of the CD2AP, podocin, synaptopodin, and filtrin antibodies, 
these proteins appeared not to be the best candidates for interaction with nephrin. The 
immunoreactivity of the CD2AP and podocin antibodies was strong in the exocrine pancreas 
while the islets of Langerhans remained practically unstained, except occasional thread-like 
signals. Mouse anti-synaptopodin exhibited a very restricted occasional circular or thread-like 
staining in the islets but not limited to the islets. Rabbit anti-filtrin showed an obvious 
immunoreactivity in the exocrine part with no apparent colocalisation with insulin. The NEPH1 
immunoreactivity with standard procedures did not show a clear specific signal remaining the 
localisation of NEPH1 elusive. 
 
The E-cadherin and ZO-1 immunofluorescence were also included in this part of the study, as the 
slit diaphragm associated protein assembly has been proposed to contain ZO-1 (Schnabel et al., 
1990) and P-cadherin (Reiser et al., 2000). Among E-, N-, and R-cadherin found in the islets 
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(Moller et al., 1992; Hutton et al., 1993; Esni et al., 1999; Esni et al., 2001; Dahl et al., 2002) E-
cadherin was chosen to replace P-cadherin, as E-cadherin has been shown to mediate most of the 
calcium dependent adhesion within the islets (Rouiller et al., 1991). Mouse anti-E-cadherin was 
found to exhibit a typical pattern with a strong immunoreactivity in the exocrine part and a 
weaker immunoreactivity in the endocrine part of the pancreas (IV). In merged image, the E-
cadherin immunoreactivity appeared to surround the insulin positivity showing a partial 
colocalisation. The ZO-1 immunoreactivity was prominent in the exocrine tissue with no obvious 
colocalisation with insulin.  
 
 
 CD2AP Pod-like FAT Den NEPH1 NEPH2 Filt Synpod Actn E-cad ZO-1 
RT-PCR + + + + + - + + ND ND ND 
Sequence + + + + + - + + ND ND ND 
WB + + + + + ND + ND + ND ND 
IF exo ++ ++ + + ND ND + +/- + ++ ++ 
IF endo - - ++ ++ ND ND +/- +/- ++ + - 
 
Table 6. Summary of the results.  The observed presence (+) or absence (-) of mRNA of the CD2AP, 
podocin-like (Pod-like), FAT, densin (Den), NEPH1, NEPH2, filtrin (Filt), synaptopodin (Synpod), α-
actinin-4 (Actn), E-cadherin (E-cad) and ZO-1 in pancreatic cDNA as judged by RT-PCR and sequencing 
of the PCR band (Sequence).  The observed presence (+) or absence (-) of the respective proteins as 
judged by immunoblotting (WB) and immunofluorescence (IF). The IF results are graded: some positivity 
(+) and more positivity (++). The observed localisation within the pancreas: in the exocrine pancreas (IF 
exo) and in the endocrine cells of the islets of Langerhans (IF endo). Other abbreviations: ND, not 
determined. 
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DISCUSSION 
 
 
1. Nephrin 
 
The NPHS1 gene is mutated in CNF (Kestila et al., 1998). CNF is characterised by 
uncontrollable proteinuria suggesting a defect in the functional glomerular filtration barrier 
(Huttunen et al., 1980; Norio and Rapola, 1989). The functional barrier, composed of the 
endothelial cells, GBM, and podycyte cell layer, prevents proteins from leaking from the blood to 
urine (Clapp and Croker, 1997). The genetic defect in the nephrin-encoding NPHS1 gene affects 
the podocyte layer of the filtration barrier (Kestila et al., 1998). The podocytes are epithelial 
octopus-shaped cells that form a dynamic web around the GBM (Clapp and Croker, 1997; 
Pavenstadt et al., 2003). The foot processes of adjacent podocytes are in contact via a specialised 
cell junction, the slit diaphragm (Tisher and Madsen, 1991). Nephrin has been localised at this 
intercellular bridge (Holthofer et al., 1999; Holzman et al., 1999; Ruotsalainen et al., 1999).  In 
CNF, nephrin is absent, and the intercellular bridge is faulty causing a fusion of the foot 
processes and proteinuria (Kestila et al., 1998; Holthofer et al., 1999; Patrakka et al., 2000).  
 
 
1.1. Sites of nephrin expression (I) 
 
Originally nephrin was shown to be podocyte-specific (Kestila et al., 1998). Unquestionably the 
podocyte appears to be the major site for nephrin expression but by now reports show the 
expression also elsewhere, including the pancreas (I), the brain (Putaala et al., 2001), and the 
spleen (Ahola et al., 1999). In this thesis work both glomerular and pancreatic nephrin was 
studied. 
 
The tissue distribution of nephrin mRNA was studied with a human tissue RNA dot blot (I). 
Among the fifty tissues studied, the expression was only detected in the fetal kidney, kidney and 
pancreas (I). No expression was found in the spleen or diverse samples of the brain, such as 
whole brain, fetal brain, cerebellum, spinal cord, and hippocampus although by now expression 
of nephrin has been reported in these tissues with other methods, e.g. RT-PCR, or ISH (Ahola et 
al., 1999; Moeller et al., 2000; Moeller et al., 2002; Putaala et al., 2000; Putaala et al., 2001; 
Wong et al., 2000). The apparent discrepancy may reflect intermetodological differences in 
sensitivity.     
 
  
1.2. Characterisation of nephrin in human pancreas (I, IV) 
 
Expression of nephrin mRNA in the pancreas was verified by RT-PCR and subsequent 
sequencing of the PCR products. The mRNA encoding sequence of nephrin in the kidney 
(GenBank accession nr. AF035835) and pancreas were found to be identical (I). The sequencing 
revealed also the presence of an alternatively spliced form of nephrin mRNA in the pancreas (I), 
as reported earlier in the kidney (Holthofer et al., 1999). This transmembrane region encoding 
exon 24 lacking form could produce a soluble form of nehprin. Alternative splicing has been 
found to create secreted isoforms and speculated to carry a potential to modify functions of 
proteins (Gower et al., 1988; Saily et al., 1998; Takase et al., 1998).  
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The sequence-based calculated molecular weight of nephrin is ~135 kDa (Kestila et al., 1998). 
The glomerular nephrin migrates as a double band, and the reported molecular weight as judged 
by immunoblotting was found to be ~185-200 kDa in the kidney glomeruli (Ahola et al., 1999; 
Holthofer et al., 1999; Holzman et al., 1999; Ruotsalainen et al., 1999). Post-translational 
modifications, such as N-glycosylation were suggested to account for the difference between the 
calculated and reported molecular weight (Kestila et al., 1998). In the pancreatic lysate the 
observed molecular weight of nephrin was ~165 kDa (I). In vitro studies using COS cells 
transfected with the full-length nephrin exhibit a band of ~150 kDa (Ruotsalainen et al., 1999; 
Huh et al., 2002), wild-type M-1 cells two bands at ~160 and 185 kDa (III, this thesis), an 
immortalised mouse podocyte cell line and a human embryonic kidney cell line transfected with 
full-length nephrin a doublet band at 185 kDa (Yan et al., 2002) suggesting the presence of 
different forms of nephrin. Inhibition of N-glycosylation was found to reduce the molecular 
weight of nephrin from 185 to 150 kDa (Yan et al., 2002). The size of pancreatic nephrin, thus, 
resembles that of unglycosylated form of nephrin. However, there is no direct evidence of 
differential glycosylation of pancreatic nephrin so far. Besides glycosylation other post-
translational modifications, like fatty acid acylation, or proteolytic cleavage, could affect the size. 
In addition, nephrin mRNA exhibits differentially spliced forms: In the rat, five alternatively 
spliced variants have been observed (Ahola et al., 1999). In the mouse, tissue-specific splicing 
has been reported (Beltcheva et al., 2003). In man, the full-length sequence of α-nephrin is not 
known. The presence of other nephrin splice variants in human pancreas or kidney has not been 
studied. Thus, the size of the 165-kDa nephrin may reflect differential post-transcriptional (i.e. 
alternative splicing) or post-translational modifications, or both (I). 
 
Pancreatic nephrin was localised in the islets of Langerhans with two different antibodies (I, IV). 
Both immunoreactivities showed colocalisation of nephrin in β-cells with insulin. In addition, no 
colocalisation was observed with glucagon, somatostatin or cytokeratin 19 positive cells (I). 
Supporting the localisation of nephrin in the islets of Langerhans, immunoblotting revealed an 
enrichment of nephrin in the islet cells when compared with the whole pancreas, and by PCR the 
amplification of nephrin cDNA was also detected in the islets of Langerhans (I). At present the 
GeneBank database (Benson et al., 2000) contains two pieces of nephrin cDNA sequence 
(BI963009 and BI966820) originating from a human islet library. When compared with the 
nephrin mRNA sequence (AF035935), the sequences cover nucleotides 340-897 and 994-1441, 
respectively (Altschul et al., 1990). 
 
Nephrin expression in the pancreas has not been widely studied. However, there are a few 
reports. In mouse pancreas, a weak expression of nephrin was observed by ISH (Wong et al., 
2000). In transgenic mice the expression of the LacZ gene under nephrin promoter was found in 
β-cells (Putaala et al., 2001). In addition, some nephrin promoter constructs were found to drive 
LacZ expression in the podocytes, brain and pancreas while some of them showed only podocyte-
specific expression suggesting a tissue-specific regulation of the promoter (Moeller et al., 2000; 
Moeller et al., 2002). A recent report confirms that alternatively used promoters and distinct 
elements direct tissue-specific nephrin expression (Beltcheva et al., 2003).  
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2. Nephrin TRAP mice 
 
2.1. Basic characterisation of nephrin TRAP mice (II) 
 
The nephrin TRAP mouse line was generated by an alternative rapid gene disruption method, 
called genetrapping. This approach is based on random insertional mutagenesis caused by a 
random integration of a strong splice acceptor vector into the genome with the help of splice 
donor/splice acceptor sites (Townley et al., 1997; Cecconi and Meyer, 2000; Wiles et al., 2000). 
Integration site of the vector can be determined by 5’ RACE. In the case of nephrin TRAP mouse 
the vector was found inserted in an inverted orientation at the 5’ end of exon 8, supplying an 
early translation stop codon (II). Due to the inverted orientation of the vector, the poly-A 
sequence of the vector was inverted to the poly-T sequence. Possibly thus, nephrin mRNA was 
found to be transcribed but the presence of the vector was found to interfere transcription 
activities. In the nephrinwt/trap kidneys the nephrin-specific transcript was found to be reduced by 
63 % as judged by quantitative PCR, and in the nephrintrap/trap kidneys even more. No nephrin 
protein was detected in the nephrintrap/trap kidneys while in the nephrintrap/wt and nephrinwt/wt 
kidneys nephrin was clearly present. In the nephrinwt/wt pancreata nephrin was found. In contrast, 
in the nephrintrap/wt and nephrintrap/trap pancreata only a barely detectable trace of nephrin could be 
seen after a long exposure of the immunoblot suggesting a residual leakage of the trap, e.g. by 
alternative splicing around the trap vector (Cecconi and Meyer, 2000). The nearly complete 
absence of nephrin in the nephrinwt/trap pancreas may be a matter of sensitivity: the amount of 
nephrin is low already in the nephrinwt/wt pancreas. Thus, a reduction in the protein level (as 
expected in the nephrinwt/trap pancreas) could lower the signal intensity below the detection limit.  
 
During embryonic development there were no obvious differences in the extent of branching of 
the kidney ureter tree between the genotypes of nephrin TRAP mice (II). The only observed 
peculiarity was an odd little branch extending from the main trunk of the ureter tree in two 
nephrintrap/trap kidneys. Nephrintrap/trap embryos were found to be overrepresented during the 
embryonic development possibly reflecting interlitter differences (only two litters genotyped). At 
birth, nephrin (-/-) mice showed ~25 % frequency (Putaala et al., 2001). These results suggest, 
that during embryonic development nephrin-deficient mice survive, and the branching events of 
the ureter tree are not seriously affected (II). However, nephrin-deficiency causes an early 
postnatal lethality, typically during the first two postnatal days (II). Among older pups 
nephrintrap/trap mice were not found.  
 
 
2.2. Nephrintrap/trap mice are proteinuric and resemble human CNF patients (II) 
 
Nephrintrap/trap mice were found to be severely proteinuric (II). Microscopic examination of the 
nephrintrap/trap kidneys revealed hypercellular glomeruli with an accumulation of extracellular 
matrix and fibrosis, dilated Bowman’s capsules, and dilated tubules with cysts. The slit 
diaphragms were found to be absent, and the podocyte foot processes were flattened and fused. 
The phenotype of these mice is essentially the same as observed in CNF patients (Huttunen et al., 
1980; Autio-Harmainen and Rapola, 1981; Norio and Rapola, 1989; Ruotsalainen et al., 2000) 
and nephrin (-/-) mice generated by targeted gene inactivation (Putaala et al., 2001; Hamano et 
al., 2002).  
 
Nephrinwt/trap mice were viable and fertile. They had no notable proteinuria. By electron 
microscopy, the slit diaphragms were present and the majority of podocyte foot processes 
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appeared normal while about one-third were flattened (II). Despite the ultrastructure of podocytes 
in young mice is not fully mature, these findings could suggest a gene dose effect. The NPHS1 
carriers are not typically proteinuric but during the fetal period they may show proteinuria 
(Jalanko et al., 2001). By electron microscopy the slit diaphragms are observed but the kidneys of 
these fetuses show fused podocyte foot processes (Jalanko et al., 2001; Patrakka et al., 2002b), 
which is in agreement with the findings in nephrinwt/trap mice. Nephrinwt/trap mice could be used to 
study the significance of heterozygosity in various situations when nephrin expression is 
challenged. 
 
 
2.3. No obvious pancreatic phenotype in nephrintrap/trap mice 
 
The pancreatic phenotype of the E17 nephrintrap/trap mice has been preliminarily studied but not 
yet characterised thoroughly. The first experiments by light microscopy, however, failed to 
exhibit major differences between the nephrintrap/trap and nephrinwt/wt pancreata. The presence of 
insulin, glucagon, somatostatin, amylase, and cytokeratin positive cells was found (unpublished). 
It appears that the role of nephrin in the pancreas and brain is not absolutely critical during 
prenatal development or that the functions of nephrin may be compensated by other proteins 
(Putaala et al., 2001). The presence of subtle defects due to loss of nephrin remains to be seen. 
Nephrin-deficient mice die typically during the first two postnatal days (II) (Putaala et al., 2001; 
Hamano et al., 2002), when the development of diverse tissues is still going on. Therefore it may 
be that the defects in the pancreas and brain need more time to appear, and conditional tissue-
specific nephrin-deficient mice should be generated to address this problem. However, no 
obvious extrarenal symptoms have been reported in CNF patients after kidney transplantation 
(Qvist et al., 1999). Mild neurologic symptoms, like ataxia, have been found but it is not known 
whether they are associated CNF and its treatment or could result from absence of nephrin in the 
brain (Putaala et al., 2001). No obvious pancreatic defects or problems with blood glucose level 
have been reported. The careful examination of the kidney-transplanted CNF patients could 
possibly reveal subtle effects of nephrin loss in the pancreas. Alternatively, difficulties to detect a 
loss-of-function phenotype could propose problems with overexpression, causing a gain-of-
function phenotype, as proposed for Drosophila Hibris, a gene related to human nephrin (Dworak 
et al., 2001). In Drosophila, overexpression has been found to prevent fusion of the myoblasts 
and cause disarrangement of muscle attachment.  
 
 
3. Identification of putative nephrin-associated proteins  
 
3.1. Immunohistochemistry of the selected podocyte proteins shows no major differences 
between nephrin TRAP genotypes (II) 
 
To determine the precise functions of nephrin in the kidney and pancreas it is important to 
identify the nephrin-associated protein assembly and characterise molecular pathways and 
cytoskeletal connections of nephrin. The kidneys of nephrin TRAP mice were immunostained 
with antibodies against selected podocyte proteins, i.e. CD2AP, podocalyxin and ZO-1, to reveal 
differences caused by loss of nephrin (II). No obvious differences between the trap genotypes 
were observed (II). Comparable results were obtained in nephrin-deficient mice when the 
immunoreactivity of several podocyte proteins, including podocin, α-actinin, CD2AP, 
synaptopodin, integrin α3, ZO-1, P-cadherin and FAT were studied (Hamano et al., 2002). 
Despite no obvious changes in the intensity of the immunoreactivities, the immunoreactivity 
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pattern of podocalyxin was found to be slightly altered (II). It appeared more punctate in the 
nephrintrap/trap kidneys (II). This kind of an alteration in the immunoreactivity pattern has been 
reported for several podocyte proteins. A punctate pattern has been reported for nephrin found in 
human nephrotic syndromes, experimental models and cultured podocytes challenged, for 
instance, with puromycin or tumor necrosis factor-α (Kawachi et al., 2000; Doublier et al., 2001). 
The ZO-1 immunoreactivity appeared to alter more discontinuous after in vivo administration of 
the 5-1-6 (nephrin) antibody (Kawachi et al., 1997). In the CD2AP-deficient mice the pattern of 
the immunoreactivity of nephrin appeared normal at birth but later was reduced and segmented in 
glomeruli (Li et al., 2000). Laminin-β2-deficient mice, in turn, exhibited a punctate CD2AP 
immunoreactivity (Li et al., 2000). In cultured podocytes, the cytoskeleton was found to be 
involved in the redistribution of the nephrin immunoreactivity (Doublier et al., 2001). The 
punctate-like immunoreactivity of podocalyxin may reflect cytoskeletal changes occured in the 
flattened podocytes of the nephrintrap/trap kidneys. Loss of nephrin may also affect the distribution 
of other proteins but the early perinatal lethality of nephrintrap/trap mice restricts the studies to early 
postnatal effects. Collectively, it seems that the proteins of the podocytes are tightly interlinked 
and regulated via the cytoskeleton: a defect at the lateral membrane (loss of nephrin) may affect 
to the apical membrane (podocalyxin) and a basal defect in the GBM (laminin-β2) to an adapter 
(CD2AP) organising the cytoskeletal connections at the lateral membrane.  
 
 
3.2. Interaction between nephrin and CD2AP (III) 
 
Since immunohistochemical studies on the nephrin TRAP kidneys could not single out the 
proteins in the immediate vicinity of nephrin, double immunofluorescence of the kidneys sections 
were performed. Nephrin was found to partially colocalise with CD2AP and podocin while no 
colocalisation was typically found with α-actinin-4 (III). Immunoelectron microscopy verified 
the localisation of nephrin in the slit diaphragm area (III), as also shown (Holthofer et al., 1999; 
Holzman et al., 1999; Ruotsalainen et al., 1999), and showed that CD2AP can be found near slit 
diaphragm in the cytoplasm (III), as also shown (Shih et al., 2001; Welsch et al., 2001). As both 
nephrin and CD2AP in the glomeruli were found to be rather insoluble, the interaction studies 
were performed with M-1 cell line expressing nephrin and CD2AP endogenously (III). In M-1 
cells, nephrin was shown to localise at the cell membrane, and CD2AP was also found in the 
vicinity of the cell membrane supporting the possibility for interaction (III). The interaction 
between endogenous nephrin and endogenous CD2AP was shown for the first time by reciprocal 
coimmunoprecipitations (III). With pulldown assays the first and third SH3 domain of CD2AP 
were found to bind to nephrin. The interaction of the first SH3 domain was more evident with the 
160-kDa nephrin. Only the interaction between the third SH3 domain of CD2AP and nephrin 
persisted in the high stringency conditions, suggesting that the third SH3 domain of CD2AP is 
apparently the main mediator of the interaction (III). The interaction site in nephrin was not 
studied but the proteins with SH3 domains typically bind proline-rich regions (Ren et al., 1993). 
For instance, CD2AP binds via its first SH3 domain to a proline rich area in CD2 (Dustin et al., 
1998). The intracellular domain of nephrin (Kestila et al., 1998) contains one Pro-X-X-Pro 
sequence corresponding to amino acids 1147-1150 (Pro-Gln-Leu-Pro) that could to be a potential 
interaction site if the interaction found between nephrin and CD2AP is direct.    
 
The interaction between nephrin and CD2AP has also been studied simultaneously elsewhere. An 
indication of a possible interaction between nephrin and CD2AP appeared when CD2AP-
deficient mice were found to develop lethal proteinuria (Shih et al., 1999b). Initial studies with 
overexpressed constructs of the intracellular part of nephrin and CD2AP suggested an interaction 
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but further studies with overexpressed constructs resulted in conflicting data. The intracellular 
part of nephrin was found to bind podocin but not CD2AP (Huber et al., 2001). In an 
immortalised wild-type cell podocyte cell line, a CD2AP antibody was shown to coprecipitate 
nephrin (Shih et al., 2001). Interestingly, nephrin was reported to locate mainly to the 
intracellular membranes in this cell line. The same study suggested that the carboxy terminus of 
CD2AP would be the mediator of the interaction between nephrin and CD2AP (Shih et al., 2001). 
The interaction was proposed to occur via a novel unknown carboxyterminal domain of CD2AP 
(among residues 428-600). The last 41 amino acids (amino acids 1201-1241) were found critical 
for the interaction while a larger fragment of nephrin (amino acids 1177-1241) appeared to 
increase the interaction.     
 
The reasons for these differing results are unknown but may result from differential experimental 
setups. In the present study, endogenous nephrin was pulled down by the individual domains of 
CD2AP (III). In the other study the overexpressed intracellular part of nephrin was used to 
pulldown truncated forms of CD2AP (Shih et al., 2001). The truncated forms of CD2AP contain 
all other domains except the deleted one (Shih et al., 2001). Therefore, the availability of other 
interaction sites is different.  CD2AP has a sequence for dimerisation in the carboxyterminal part 
and has been shown to homodimerise (Kirsch et al., 1999). Endogenous ubiquitous CD2AP 
could, thus, play a role in the interactions but the possibility of an involvement of other proteins 
cannot be ruled out either. M-1 cells appear to have α-actinin-4 and low levels of podocin (III). 
In M-1 cells the localisation of podocin in the plasma membrane could support a possibility of 
interaction with nephrin or CD2AP. In the lipid rafts podocin has been shown to interact with 
nephrin and CD2AP (Schwarz et al., 2001). No involvement of podocin in the pulldown 
experiment, however, was found after restaining the respective filters with the podocin antibody 
(unpublished data). HeLa cells used in the expression of the truncated forms of CD2AP and the 
intracellular part of nephrin (Shih et al., 2001) express endogenously at least CD2AP (Dustin et 
al., 1998). An alternative explanation for the differing results could be the existence of at least 
two distinct interactions between nephrin and CD2AP regulated for instance by other proteins in 
the vicinity, or their phosphorylation status. 
 
 
3.3. Suggested nephrin-associated protein complex of the slit diaphragm 
 
By now nephrin has been shown to interact with CD2AP (III) (Shih et al., 1999b; Schwarz et al., 
2001; Shih et al., 2001), podocin (Huber et al., 2001; Schwarz et al., 2001; Sellin et al., 2002) and 
NEPH1 (Barletta et al., 2003), and the focus, thus, has turned to the recognition of other proteins 
of the slit diaphragm and to the characterisation of their intermolecular relationships in the slit 
diaphragm complex. All NEPH family members, NEPH1, NEPH2, and NEPH3 (filtrin) have 
been found to interact with podocin (Sellin et al., 2002) and ZO-1 (Huber et al., 2003). The 
interactions of NEPH1 with ZO-1 and podocin seem to be regulated by phosphorylation. Densin 
was found in the coimmunoprecipitation with the nephrin antibody and was located thereafter to 
the slit diaphragm region (unpublished). The detailed interactions of densin at the slit diaphragm 
are still unknown. At the PSD, the other reported location, densin has been found to interact with 
δ-catenin and N-cadherin (Izawa et al., 2002). Delta-catenin binds to S-SCAM (a MAGI-1 
protein) that also interacts with other transmembrane proteins of the PSD (Izawa et al., 2002). At 
the slit diaphragm the cadherin components reported to be present are P-cadherin (Reiser et al., 
2000), and FAT (Inoue et al., 2001). The interactions of FAT at the slit diaphragm are unknown 
but the intracellular part contains potential sequences for interaction with β-catenin. The 
intracellular part of P-cadherin has been proposed interact with β- and/or γ-catenin (Reiser et al., 
 55 
2000). This complex has been shown to bind α-catenin (Ozawa et al., 1990), which could link the 
complex via ZO-1 (a MAGUK protein) or α-actinin to the actin cytoskeleton (Reiser et al., 
2000). Another MAGI-1 protein present in the podocytes has been found to interact with 
synaptopodin and α-actinin-4 (Patrie et al., 2002). Synaptopodin, an actin-binding protein 
(Mundel et al., 1997b) has been reported to colocalise with CD2AP (Shih et al., 1999b) and 
podocin (Schwarz et al., 2001; Roselli et al., 2002b). Instead, α-actinin-4 was not typically found 
to colocalise with nephrin in kidney sections (III) but it was observed in close spatial association 
of nephrin. Besides ZO-1, α−actinin-4, and synaptopodin, also CD2AP appears to interact 
directly with the actin cytoskeleton (Lehtonen et al., 2002). Taken together, it seems that the 
nephrin-associated protein assembly in the kidney podocytes has begun gradually to take shape. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Hypothetical presentation of the molecules of the emerging nephrin-associated complex at 
the slit diaphragm (modified from Smoyer and Mundel, 1998; Tryggvason et al., 1999; Somlo and 
Mundel, 2000; Kerjaschki, 2001; Khoshnoodi and Tryggvason, 2001b). 
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3.4. Search for the nephrin-associated protein complex of the islet β-cell (IV) 
 
No loss-of-function pancreatic phenotype of nephrin is known at present, which complicates the 
recognition of nephrin-associated proteins. On the other hand, the recognition of the nephrin-
associated proteins in the pancreas could provide clues to the functions of pancreatic nephrin. 
When the nephrin-associated protein complex in the podocytes is becoming known, one approach 
to identify potential pancreatic nephrin interacting proteins is to study the presence of these 
proposed proteins - CD2AP, podocin, NEPH1, NEPH2, filtrin (NEPH3), FAT, densin, α−actinin-
4, synaptopodin, ZO-1, and cadherin in the pancreas.  
 
CD2AP, NEPH1, filtrin (NEPH3), FAT, densin, α−actinin-4, and synaptopodin were found in the 
pancreas (IV). The presence of podocin could not be confirmed although the results suggest an 
existence of a podocin-like (or stomatin-like) protein in the pancreas. No NEPH2 mRNA was 
found in the pancreas. ZO-1 and cadherin are known to be present in the pancreas on the basis of 
previous studies. ZO-1 has been found in the ductal cells of the exocrine pancreas (Kleeff et al., 
2001). E-cadherin as well as N- and R-cadherin are known to be present in the islet β-cells 
(Cirulli et al., 1994; Esni et al., 1999). 
 
Immunohistochemical localisation was used to single out those proteins of the proposed nephrin-
associated assembly present in the β-cells, the reported location of nephrin (I). FAT, densin, E-
cadherin, and α-actinin-4 were found in the islets of Langerhans (IV). Their immunoreactivity 
pattern and/or colocalisation with insulin or nephrin showed their presence in β-cells. Instead, the 
observed immunoreactivity patterns of CD2AP, a podocin-like protein, synaptopodin, ZO-1 or 
filtrin suggest that these proteins are not likely among the best candidates for interacting with 
nephrin in the pancreas (IV). Thus, the nephrin-associated protein complex in the kidney and 
pancreas does not seem to be identical, but interestingly, transmembrane adhesion molecule 
and/or signalling receptor type proteins, FAT, densin, and cadherin appear to be shared with the 
β-cells and podocytes while the more adapter-like and actin-binding molecules, like CD2AP 
(Dustin et al, 1998; Lehtonen et al, 2002), synaptopodin (Mundel et al, 1997), and ZO-1 (Itoh et 
al, 1997) are practically absent in the islets. However, the actin-bundling α-actinin-4 is observed 
in β-cells. It could participate in coupling the actin cytoskeleton via catenins to E- or N-cadherin 
(Ozawa and Kemler, 1992; Knudsen et al., 1995; Dahl et al., 1996).  
 
N-CAM, which is present in β-cells, has been shown to have profound effects on the islet 
architecture as well as on the cell junction formation, polarisation and insulin turnover (Cirulli et 
al., 1994; Esni et al., 1999), and thus might be an interesting molecule to study in context of 
nephrin. Taken together, nephrin, FAT, densin, α−actinin-4, a cadherin component of the 
proposed nephrin-associated protein assembly and N-CAM have been found in the β-cells, and 
thus, may have a potential for interactions. Further studies with immunoelectron microscopy 
should be performed to reveal the subcellular localisation of these molecules.      
 
 
4. Functions of nephrin 
 
Functions of nephrin are not thoroughly known. Based on the domain structure consisting of Ig-
like domains, a fibronectin-type III domain, a transmembrane region and eight tyrosines in the 
intracellular part, nephrin is a putative member of the Ig superfamily (Kestila et al., 1998; 
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Lenkkeri et al., 1999). In the kidney, nephrin has been proposed form the structural-functional 
basis of the interpodocyte slit membrane (Kestila et al., 1998; Tryggvason, 1999; Tryggvason et 
al., 1999). The identification of mutations in the NPHS1 gene responsible for the proteinuria in 
CNF (Kestila et al., 1998) as well as the evidence of downregulation of nephrin in other human 
nephrotic syndromes (Furness et al., 1999; Doublier et al., 2001; Srivastava et al., 2001; Kim et 
al., 2002; Wang et al., 2002) and in experimental rat models of nephrosis (Kawachi et al., 2000; 
Luimula et al., 2000a; Luimula et al., 2000b; Yuan et al., 2002b) support a role for nephrin as an 
essential component of the slit membrane maintaining the glomerular filtration barrier 
(Tryggvason, 1999; Tryggvason et al., 1999). In addition to this structural role, nephrin has been 
shown to participate in cell signalling (Huber et al., 2001; Simons et al., 2001). The functions of 
the differentially spliced forms of nephrin are not known (Ahola et al., 1999; Holthofer et al., 
1999; Beltcheva et al., 2003).  
 
At present, it is too early to suggest a precise role for nephrin in the β-cells. As described, 
pancreatic and glomerular nephrins differ in certain respects. Pancreatic nephrin may be 
alternatively spliced or/and differentially modified after translation (I). This may affect the 
adhesive properties of the proteins, and subsequently the functions (Brummendorf and Rathjen, 
1994; Juliano, 2002). In general, the members of the Ig superfamily have a variety of functions in 
cell adhesion, signalling, and migration (Brummendorf and Rathjen, 1994; Juliano, 2002). In the 
CNS, the nephrin-positive cells have been identified as radial glia-cells implicated in cell 
migration (Hatten, 1999; Putaala et al., 2001). The role of nephrin in these cells also remains 
elusive.  
 
It is, however, tempting to speculate a role of nephrin in the pancreas. Early endocrine cells 
migrate during pancreatic development from the epithelium into the mesenchyme where they 
eventually form the islets (Scharfmann, 2000). Integrins αvβ3  and  αvβ5 (Cirulli et al., 2000), 
TGF-β (Miralles et al., 1998b) and EGF-R signalling (Miettinen et al., 2000) appear to be 
involved in adhesion and migration. In general, the molecules guiding migration and subsequent 
aggregation into islets are poorly known. The islet cell segregation (i.e. forming the β-cell core 
surrounded by the non-β-cells) is neither fully understood. It has been hypothesised that 
segregation would result from differential expression of adhesion molecules in the β- and non-β-
cells (Rouiller et al., 1991). However, the calcium-dependent (i.e. cadherin-mediated) adhesion 
has been found similar in the β- and non-β-cells, and E-cadherin has been shown to account for 
most of the calcium-dependent adhesion, thus suggesting a role in the basic adhesiveness of the 
islet cells (Rouiller et al., 1991). Among cadherins, only R-cadherin found at low levels 
predominantly in the cytoplasm of the β-cells has been found to be differentially expressed 
between the islet cells (Esni et al., 1999). Its function in the β-cells has not been reported so far, 
and R-cadherin-deficient mice have reported to show no loss-of-function phenotype in the 
pancreas (Dahl et al., 2002). N-CAM has been shown to be involved in the islet cell segregation 
despite it is also expressed in the β- and non-β-cells (Cirulli et al., 1994; Esni et al., 1999). In N-
CAM-deficient mice the defects in the cell segregation become evident at the age of 4-5 weeks 
after birth. In addition, these mice show enhanced clustering of E- and N-cadherin, actin 
cytoskeleton-dependent cell polarisation, formation of so-called endocrine acini, and show 
reduced numbers of insulin granules (Esni et al., 1999). It seems that N-CAM negatively 
regulates in the clustering. As a novel β-cell specific protein nephrin could be a good candidate 
for participating in the establishment of the islet architecture and its maintenance. The other 
novel adhesion molecule and/or signalling receptor type proteins, FAT and densin (IV), could 
also be involved. Alpha-actinin could be involved in linking the protein complex to the actin 
cytoskeleton. 
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This kind of a role would resemble the role nephrin has in the podocytes. At the slit diaphragm, 
nephrin and the proteins in its vicinity have been shown to form important functional complexes 
linking the slit diaphragm to the actin cytoskeleton (Khoshnoodi and Tryggvason, 2001; Smoyer 
and Mundel, 1998; Somlo and Mundel, 2000; Tryggvason et al, 1999). The interference in 
nephrin or the associated protein complex has been shown to result in the disruption of the 
podocyte architecture, an effacement of the podocyte foot processes, and proteinuria (Boute et al, 
2000; Donoviel et al, 2001; Kaplan et al, 2000; Kawachi et al, 1997; Kestila et al, 1998; Shih et 
al, 1999).  
 
The Notch signalling has been shown to regulate Drosophila Hibris, a nephrin related gene 
(Artero et al., 2001; Dworak et al., 2001). The Notch signalling has also been implicated in the 
cell type specification in the pancreas (Edlund, 2002). FAT, also found in the β-cells and 
podocytes, contain domains (Dunne et al., 1995) that are typically present in the proteins of 
Notch signalling, like in Notch and its ligand, Delta (Eiraku et al., 2002).  
 
 
5. Nephrin in renal diseases - and in diabetes? 
 
Besides CNF, nephrin has also been reported to be affected in other proteinuric syndromes. 
Typically, downregulation of nephrin and/or a discontinuous immunoreactivity of nephrin have 
been reported in several kidney diseases, for instance in membranous glomerulonephritis 
(Furness et al., 1999; Doublier et al., 2001; Kim et al., 2002), minimal change nephropathy 
(Furness et al., 1999; Doublier et al., 2001; Srivastava et al., 2001), focal segmental 
glomerulosclerosis (Doublier et al., 2001; Srivastava et al., 2001; Kim et al., 2002) as well as in 
diabetic nephropathy (Langham et al., 2002).  
 
Diabetic nephropathy, a complication of diabetes, has been related to poor glycemic control 
(Odoni and Ritz, 1999). Despite intense studies, the exact molecular events leading to diabetic 
nephropathy have remained elusive. Among several suggested factors, the activation of protein 
kinase C has shown to be involved in the changes in diabetic nephropathy (Koya and King, 
1998). Upregulation of nephrin is found in the early phases of diabetic nephropathy (Aaltonen et 
al., 2001) as well as after the activation of protein kinase C (Wang et al., 2001a). In the later 
stages of diabetic nephropathy, nephrin expression - probably due to scarring and loss of the 
podocyte function - becomes downregulated (Langham et al., 2002). Interestingly, 
downregulation of nephrin could be prevented by blocking the renin angiotensin system in 
human diabetic nephropathy (Langham et al., 2002) and experimental models of proteinuria 
(Benigni et al., 2001; Bonnet et al., 2001; Cao et al., 2002; Kelly et al., 2002). The molecular 
mechanisms involved are unknown at present but it appears that renoprotection by drugs that 
block with angiotensin II synthesis or activity seems to be related to nephrin. 
 
In CNF, circulating nephrin autoantibodies may have a pathogenic role in the recurrence of 
nephrotic syndrome after transplantation (Wang et al., 2001b; Patrakka et al., 2002a). The kidney 
transplantation introduces nephrin as a neoantigen inducing the production of nephrin 
autoantibodies in some CNF patients. The autoantibodies may perturb the kidney function and 
lead to the recurrence of nephrotic syndrome. After kidney transplantation nephrin is still absent 
in the pancreas of the CNF patients, and thus, the nephrin autoantibodies likely not perturb the β-
cell functions. However, it seems based on the pilot study that some patients with type I diabetes 
may also have nephrin autoantibodies (unpublished). In addition, the preliminary results with the 
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non-obese diabetic mouse model of human type I diabetes, show an upregulated expression of 
pancreatic nephrin in the pancreas (unpublished). The expression is found to be upregulated 
already at the age of 3 weeks, prior to the onset of the lymphocyte infiltration into the pancreas, 
which is followed by the destruction of the β-cells and development of diabetes. The upregulated 
expression could reflect the ongoing inflammation process. If nephrin had a role in the 
maintenance of the islet architecture, the increased expression could refer to an increased 
challenge to preserve the islet structure, known to be important for its proper function (Gepts and 
Lecompte, 1981; Gomez Dumm et al., 1990; Tokuyama et al., 1995; Esni et al., 1999).  
 
As a novel protein shared by the kidney and pancreas, nephrin studies focus on the pathogenesis 
of diabetes and diabetic nephropathy. The incidence of these chronic diseases is sharply 
increasing. The number of patients with diabetes has been estimated to double by 2025 (Alberti, 
2001), increasing subsequently the number of patients with diabetic nephropathy and the disease-
related costs to the society. Thus, a better understanding of molecular mechanisms in normal and 
diseased kidneys and pancreata become crucial for the prevention, diagnostics and better 
management of these diseases.  
 
 
6. Final conclusions 
 
In conclusion, nephrin, originally suggested to be a podocyte-specific protein, was also 
discovered in the β-cells of human pancreas. The loss-of-function phenotype of nephrin TRAP 
mice in the kidney was found to resemble that of CNF patients whereas the characterisation of 
the pancreatic phenotype is ongoing. The understanding of the nephrin-associated protein 
assembly in the kidney podocytes is taking shape. Some of its interactions, like the interaction 
between nephrin and CD2AP have been characterised. The nephrin-associated protein complex in 
the podocyte and in the islet β-cell appears to differ. Interestingly, the receptor or/and signalling 
molecule like proteins of the proposed nephrin-associated assembly were also found in the 
pancreatic β -cells, and they thus may interact with pancreatic nephrin. Further studies on nephrin 
and its associated protein complex are important for determining the exact molecular mechanisms 
of this protein complex in normal and diseased conditions to clarify their value in diagnostics and 
disease management. 
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